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ABSTRACT 
 
Friedreich’s Ataxia (FA) is an autosomal-recessive, neurodegenerative disease 
characterized by progressive lower extremity muscle weakness and sensory loss, 
balance deficits, limb and gait ataxia, and dysarthria.  FA is considered a sensory ataxia 
because the dorsal root ganglia and spinal cord dorsal columns are involved early in the 
disease, whereas the cerebellum is affected later. Balance deficits and gait ataxia are 
often evaluated clinically and in research using clinical rating scales. Recently, 
quantitative tools such as the Biodex Balance System SD and the GAITRite Walkway 
System have become available to objectively assess balance and gait, respectively. 
However, there are limited studies using instrumented measures to quantitatively 
assess and characterize balance and gait disturbances in FA, and longitudinal, 
quantitative analyses of both balance and gait have not been investigated in this patient 
cohort. The purpose of the present study was to characterize gait patterns of adults with 
FA and to identify changes in gait and balance over time using clinical rating scales and 
quantitative measures. Additionally, this study investigated the relationship between 
disease duration, clinical rating scale scores and objective measures of gait and 
balance. 
This study used a longitudinal research design to investigate changes in balance 
and gait in 8 adults with genetically confirmed FA and 8 healthy controls matched for 
gender, age, height, and weight. Subjects with FA were evaluated using the Berg 
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Balance Scale (BBS), the Friedreich’s Ataxia Rating Scale (FARS) and  instrumented 
gait and balance measures at baseline, 6 months, 12 months and 24 months. Controls 
underwent the same tests at baseline and 12 months. Gait parameters were measured 
utilizing the GAITRite Walkway system with a focus on gait velocity, cadence, step and 
stride lengths, step and stride length variability and percent of the gait cycle in swing, 
stance and double limb support. Balance was assessed using the BBS and the Biodex 
Balance System; the latter included tests of postural stability and limits of stability.  
At baseline, there were significant differences in gait and balance parameters, 
BBS scores and FARS total scores between FA subjects and controls as determined 
using paired t-tests (p<0.05). Adults with FA walked slower, showed decreased 
cadence, took shorter strides, exhibited greater gait variability and spent less time in 
swing phase and more time in stance phase and double limb support. In addition, 
subjects with FA exhibited higher postural stability indices and lower limits of stability 
overall directional control scores (p<0.05). In the control group, with the exception of the 
limits of stability forward directional control score (p=0.008), no other significant 
changes in clinical rating scale scores or gait and balance measures were apparent. 
Using linear mixed effect (LME) modeling, several gait parameters of subjects with FA 
exhibited a significant linear change from baseline to 24 months including: gait velocity 
and cadence during comfortable and fast walking, step and stride length during 
comfortable and fast walking, and step length variability during fast walking (p<0.05). 
The LME also revealed a significant linear change in BBS scores, in the postural 
stability overall stability and anterior posterior indices, and in the limits of stability 
backward directional control scores (p<0.05). Numerous significant correlations were 
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noted between disease duration, BBS scores and FARS total scores and balance and 
gait parameters. Of particular note was the strong association between clinical rating 
scale scores, balance parameters and step and stride length variability (p<0.05). 
This is the first longitudinal study to demonstrate changes over time in gait and 
balance of adults with FA using both quantitative measures and clinical rating scales. 
This study provided a detailed characterization of the gait pattern and balance of adults 
with FA. The GAITRite Walkway system proved to be a sensitive measure, and able to 
detect subtle changes in gait parameters over time in adults with FA. In addition, the 
BBS was an appropriate and sensitive assessment to detect changes in static and 
dynamic balance in this patient cohort. Finally, results revealed a strong and consistent 
relationship between clinical rating scale scores, postural stability indices, limits of 
stability scores, and step and stride length variability in individuals with FA. 
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CHAPTER ONE 
INTRODUCTION 
 
What is Ataxia?  
  Ataxia is incoordination of movement due to causes other than primary muscle 
weakness. Ataxia can be caused by damage to motor or sensory regions of the central 
nervous system, as well as from peripheral nerve pathology, but the most common 
cause of ataxia is damage to the cerebellum (Bastian, 1997).  Some of the most 
distinctive clinical signs of ataxia are impairments of balance and gait. Balance 
abnormalities are characterized by increased postural sway, decreased limits of stability 
(LOS), excessive responses to perturbation, poor control of equilibrium during motions 
of other body parts, and abnormal oscillations of the trunk (titubation). Gait ataxia, or 
walking incoordination, has distinctive features including unsteadiness, reduced step 
and stride length, irregular foot trajectories, variable foot placement, a veering path of 
movement, abnormal interjoint coordination patterns and sometimes a widened stance 
(Earhart et al., 2001; Morton et al., 2004; 2010; Palliyath et al., 1998). 
  There are three types of ataxia: cerebellar, sensory and vestibular. Cerebellar 
ataxia can result from degenerative disease, stroke, or from tumors of the cerebellum. 
Damage to the pathways that provide input to or output from the cerebellum can also 
result in ataxia. These pathways include the dorsal and ventral spinocerebellar 
pathways, the corticopontocerebellar pathway and the cerebellar peduncles (which 
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relay information in and out of the cerebellum). Demyelinating diseases such as multiple 
sclerosis can lead to ataxia due to loss of signal propagation in any of the structures 
mentioned. Damage to nervous system structures such as the thalamus, which receive 
cerebellar input, can cause ataxia and tremor. Ataxia can also be caused by disruption 
of sensory and proprioceptive input from the periphery. This “sensory” ataxia results 
from damage to sensory afferents in peripheral nerves, dorsal root ganglion cells, dorsal 
nerve roots entering the spinal cord, and the dorsal columns of the spinal cord. Sensory 
ataxia can be distinguished from cerebellar ataxia, because in the former signs and 
symptoms worsen significantly when movements are made with the eyes closed 
(Bastian, 1997; Lundy-Ekman, 2007). Individuals with sensory ataxia are able to 
compensate for the loss of distal somatosensory input through the use of vision and will 
often watch their feet as they walk. However, balance deficits become much more 
pronounced when the person closes their eyes. Individuals with sensory ataxia also 
show impaired proprioception and vibratory sense, which is intact in those with 
cerebellar ataxia. Some diseases, such as Friedreich’s Ataxia (FA), can lead to a mixed 
sensory and cerebellar ataxia. Ataxia can also result from vestibular disorders, though 
this is not as common. Vestibular ataxia must be differentiated from cerebellar or 
sensory ataxia through clinical examination of the three systems. In vestibular disorders, 
abnormal vestibulospinal, corticospinal, reticulospinal, or tectospinal tract activity cause 
disequilibrium, imbalance and ataxia (Lundy-Ekman, 2007).  
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Anatomy of Ataxia  
  The Dorsal Column Medial Lemniscal System   
Regulation of movement and balance by the cortex and cerebellum is highly 
dependent upon sensory afferent information. Peripheral sensory receptors and 
peripheral nerves provide information to the central nervous system about position of 
the limbs, position of the body in space and about the environment in which the person 
is moving. Information related to discriminative touch and conscious proprioception is 
conveyed from the peripheral nervous system to the brain via the dorsal column medial 
lemniscal system. Discriminative touch allows for localization of touch and vibration. 
Conscious proprioception is awareness of movement and the ability to sense the 
position of one’s body parts in space. Sensation, which requires precise localization on 
the body surface, is mediated by the dorsal column medical lemniscal system. This 
information is used to make movements smooth, and disruption of this system can 
result in movement incoordination and balance deficits.   
The dorsal column medial lemniscal system uses a three neuron relay system 
(Lundy-Ekman, 2007) as depicted in Figure 1. The primary, first order neuron conveys 
information from the distal sensory receptor to the medulla. The second order neuron 
conveys information from the medulla to the thalamus and the tertiary neuron conveys 
information from the thalamus to the somatosensory cortex. Components of the medial 
lemniscal system include distal sensory receptors, peripheral nerves, cells in the dorsal 
root ganglia, tracts in the dorsal column of the spinal cord, brainstem nuclei, parts of the 
thalamus and the somatosensory cortex. Stimulation of sensory receptors at the distal 
end of the primary neuron generates action potentials which travel to the cell body  
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Figure 1. Dorsal Column Medial Lemniscal System 
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located in the dorsal root ganglion. The primary neuron’s proximal axon enters the 
spinal cord in the dorsal root and ascends in the ipsilateral dorsal column. Axons from 
the lower limb occupy the more medial portion of the dorsal column, named the 
fasciculus gracilis. Axons from the upper limbs occupy the lateral portion of the dorsal 
column, named the fasciculus cuneatus. Fibers that ascend in these spinal cord tracts 
synapse with second order neurons in the nuclei gracilis and cuneatus of the medulla. 
Axons from these second order neurons then decussate and ascend as the medial 
lemniscus terminating in the ventral posterolateral nucleus of the thalamus. Thalamic 
third order neurons relay information to the somatosensory cortex after passing through 
the internal capsule (Lundy-Ekman, 2007). The dorsal column medial lemniscal system 
is composed of large, myelinated, rapidly conducting fibers. These large, myelinated 
fibers have high energy demands and are particularly vulnerable to the oxidative stress, 
cell damage and demyelination seen in neurodegenerative diseases such as FA (Morral 
et al., 2010). The medial lemniscal system is one of the first nervous system areas 
involved in FA and it is critically important to coordinated movement, balance and gait 
because it is responsible for afferent transmission of discriminative sensations and 
proprioception. 
 
The Cerebellum and Spinocerebellar System  
The human cerebellum has three primary regions (Purves et al., 2008). The 
cerebrocerebellum includes the most lateral parts of the cerebellar hemispheres. It 
receives input from the cerebral cortex via the pontine nuclei and sends fibers to the 
ventrolateral thalamus which then connect to the primary and pre-motor cortical areas. 
6 
 
The cerebrocerebellum is involved in planning movements and evaluating sensory 
information during movement. The vestibulocerebellum (floculonodular lobe) receives 
inputs from the semi-circular canals and the brainstem vestibular nuclei and sends 
fibers back to the vestibular nuclei. The vestibulocerebellum primarily regulates 
movements underlying postural control, balance and equilibrium, as well as the 
vestibulo-ocular reflex. The spinocerebellum consists of the more medial and 
intermediate parts of the cerebellar hemispheres. The medial strip is called the vermis 
and is primarily responsible for trunk and proximal limb movements. The intermediate 
section, called the paravermis, is concerned with distal limb movements. The 
spinocerebellum receives proprioceptive input from the dorsal column medial lemniscal 
system, the trigeminal nerves and from visual and auditory systems and sends fibers to 
the deep cerebellar nuclei, which then project to the cerebral cortex to modulate 
descending motor systems.  
The spinocerebellum can elaborate spinal proprioceptive input to anticipate 
future positions of body parts during movements – a feed forward motor control system.  
It does this by receiving input from proprioceptors within muscles (muscle spindles and 
golgi tendon organs) and through feedback input from the spinal cord pattern 
generators. Input from the trunk and lower extremities to the spinocerebellum is greater 
than that from the upper extremities. Input from the spinal cord travels to the 
spinocerebellum via two pathways: the dorsal and ventral spinocerebellar tracts. 
Information that travels in these tracts is not consciously perceived. The dorsal 
spinocerebellar tract relays precise information about individual muscle activity and 
provides sensory feedback during movement. The ventral spinocerebellar tract appears 
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to be involved in rhythmic, automatic movements such as walking. The spinocerebellum 
also receives information from the cortex about motor commands. It is, thus, 
responsible for comparing ongoing movements (input from muscles and joints) with 
intended movements (input from cortex) for both voluntary movement and rhythmic, 
automatic movements like walking. When the function of the spinocerebellum or its 
afferent and efferent pathways is impaired, balance and gait disturbances occur.  
The central cerebellum contains four deep nuclei: the dentate nucleus, two 
interposed nuclei (emboliform and globose) and the fastigial nucleus. Each nucleus 
receives input from different parts of the cerebellar cortex and most output fibers from 
the cerebellum originate from these deep nuclei. The dentate nucleus is the largest and 
most lateral of the four pairs of deep nuclei. It receives afferent information from the 
premotor and supplementary motor cortex and sends efferent signals via the superior 
cerebellar peduncle to the ventrolateral thalamus. Dorsal dentate fibers project to motor 
areas of the cerebral cortex and are thought to be responsible for the planning, initiation 
and control of voluntary movements. The ventral region of the dentate nucleus projects 
to prefrontal and posterior parietal cortical areas and is proposed to be involved in 
conscious thought and visuospatial functions (Dum et al., 2003).  
 
Friedreich’s Ataxia   
Friedreich’s Ataxia (FA) is a progressive, neurodegenerative disease, which can 
affect multiple body systems, with symptoms ranging from gait and balance 
disturbances to cardiomyopathy and diabetes (Marmolino, 2011). FA is the most 
prevalent inherited ataxia, affecting about 1 in every 50,000 people with a carrier 
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prevalence of 1 in 110 people (Friedman, 2010; Maring et al., 2007). FA is an 
autosomal recessive disorder caused by mutations in the frataxin gene (FXN) mapped 
on chromosome 9q13 (Marmolino, 2011). Autosomal recessive means that an individual 
can only develop disease if they inherit a copy of the defective gene from both parents.  
The FXN gene encodes a small mitochondrial protein called frataxin, an 18 kDa 
soluble protein with 210 amino acids. FA results from a deficiency of this frataxin 
protein, typically expressed at 5-30% of normal levels (Campuzano et al., 1997). There 
are 3 types of FXN mutations: the expanded GAA repeat; premature termination of 
translation; or a loss-of-function missense mutation. Each of these mutations causes a 
loss of frataxin function. The last two mutations cause either a decrease in frataxin 
levels or in its incorrect function despite normal levels. The expanded GAA repeat 
results in stopping transcription of the FXN gene by inducing heterochromatin formation 
in the flanking sequence or by adopting an abnormal DNA structure (Bidichandani et al., 
1998). These mechanisms result in a severe deficiency of FXN transcription, thus a 
deficiency in frataxin protein. The frataxin protein deficiency is in direct proportion to the 
length of the expanded GAA repeat and is the reason that repeat length correlates with 
disease severity and rate of progression. A direct correlation has been established 
between the size of the GAA repeat and an earlier age of onset, more rapid rate of 
disease progression, earlier age of confinement to a wheelchair, cardiomyopathy, and 
the presence of other complications such as diabetes, scoliosis, visual or hearing loss 
(Pandolfo, 2009).   
 The most common genetic mutation in FA is the GAA repeat expansion within 
the first intron of the FXN gene. In healthy individuals, the number of repeats ranges 
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from 6 to 36, but in people with FA the repeats can range from 70-1700, most 
commonly 600-900 (Schmucker et al., 2010). Most patients with FA (96%) have two 
expanded GAA alleles, which causes reduced frataxin expression in all body tissues. A 
small number of FA patients (4%) are heterozygous with a GAA repeat mutation on one 
allele and a micromutation on the other allele. The FXN gene is expressed in all cells of 
the body but at variable levels, which can be accounted for only partially by differences 
in mitochondria (Pandolfo, 2009). The tissues that are affected primarily in FA normally 
express high levels of frataxin. Campuzano et al. (1997) showed that the highest level 
of frataxin expression is in the heart with intermediate levels in the liver, skeletal 
muscles and pancreas. Similar studies of the central nervous system showed high 
levels of expression in the dorsal root ganglion, the spinal cord, less in the cerebellum, 
and very little in the cerebral cortex (Delatycki et al., 2000). It has been demonstrated in 
knock-out mice that total absence of frataxin protein leads to early embryonic death 
(Puccio, 2009).  
The physiological effects of frataxin deficiency include a disruption of iron-sulfur 
cluster enzymes, excess iron in the mitochondria and cellular inability to regulate iron 
levels, thus an increased sensitivity to oxidative stress. Early evidence linking frataxin to 
iron metabolism was the discovery of increased iron levels in the hearts of patients who 
had succumbed to FA. Studies utilizing mouse models with frataxin deletions in specific 
tissues demonstrated that the primary problem at the cellular level in FA is the iron-
sulfur cluster protein deficiency followed by secondary mitochondrial iron accumulation. 
It is accepted that frataxin deficiency leads to mitochondrial and extra-mitochondrial 
iron-sulfur cluster deficits. This research suggests that frataxin has a critical role in 
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regulation of mitochondrial iron transport (Schmucker et al., 2010). Thus, frataxin 
deficiency leads to a loss of iron-sulfur clusters, which leads to mitochondrial 
impairment. The mitochondrial impairment then leads to an increased production of 
reactive oxygen species, which often results in excess free radicals. The excess free 
radicals result in cell damage and cell death particularly in tissues with high energy 
demands such as cardiac muscle, pancreatic islet cells and nervous system cells 
(Maring et al., 2007). 
The primary and early nervous system changes in FA include neuronal cell loss 
and shrinkage in the dorsal root ganglia and the dorsal columns of the spinal cord (Della 
Nave et al., 2008; Marmolino, 2011). There is degeneration of the gracilis and cuneatus 
tracts in the dorsal column and of the spinocerebellar tracts in the lateral columns of the 
spinal cord (Della Nave et al., 2008; Lamarche et al., 1984). Secondary neuronal loss in 
the brainstem involves the cuneate and gracilis nuclei of the dorsal medulla. There is a 
striking loss of neurons and loss of myelinated fibers in the dentate nucleus of the 
cerebellum, whereas the cerebellar cortex is spared (Della Nave et al., 2008; 
Marmolino, 2011). Cell loss and astrocytosis also occur in the brainstem vestibular and 
cochlear nuclei and in the superior olives, whereas the inferior olives are spared. The 
other deep nuclei (interposed and fastigial) and efferent pathways of the cerebellum and 
the corticospinal tracts degenerate much later in the disease (Della Nave et al., 2008; 
Lamarche et al., 1984). There is gray matter volume loss in the dorsal medulla, rostral 
cerebellar vermis, and in the inferomedial cerebellar hemispheres in FA, but no atrophy 
of the cerebral hemispheres (Della Nave et al., 2008).  
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The neurological signs and symptoms of this inherited disease correlate closely 
with the degenerative changes occurring in the nervous system. Symptoms usually 
begin between the ages of 5 and 15 and typically present as gait and limb ataxia and 
balance deficits (Delatycki et al., 2000). There is a gradual loss of position and vibratory 
sense and light touch sensation in the extremities with the pattern of loss starting distal 
and symmetrical and progressing proximally (Maring et al., 2007). Incoordination and 
intention tremor develop in all extremities with progressive and symmetrical loss of 
muscle strength (lower extremities > upper extremities and trunk). Lower extremity deep 
tendon reflexes are diminished early, while spasticity and positive plantar reflexes 
(positive Babinski sign) are seen later in the disease due to corticospinal tract 
degeneration. A positive Babinski sign involves dorsiflexion of the great toe with fanning 
of the other toes upon stimulation of the sole of the foot (Lundy-Ekman, 2007). Lower 
extremity muscle weakness begins in the hip extensors and abductors, but as the 
disease progresses, distal limb muscle weakness and muscle wasting become 
pronounced. The upper extremity and trunk musculature are spared until later in the 
disease process. Spasticity in the lower extremities affects the ankle plantarflexors and 
invertors leading to ankle equinovarus deformity later in the disease (Maring et al., 
2007).  
Individuals with FA develop progressive ataxia beginning with impaired balance 
when walking and incoordination of the lower limbs more than the upper limbs. Gait 
ataxia, caused by a combination of spinocerebellar degeneration and loss of 
proprioceptive and vibratory sense in the lower extremities is often the earliest 
symptom. Within five years of symptom onset, most people with FA exhibit dysarthria 
12 
 
(slurred speech), lower extremity muscle weakness and diminished or absent joint 
position and vibratory sensation particularly in the feet. Involvement of peripheral 
sensory neurons and motor neurons result in a progressive, mixed axonal, peripheral 
neuropathy. Other problems associated with FA include scoliosis, pes cavus, optic 
nerve atrophy with visual loss, abnormal extraocular movements, sensorineural hearing 
loss, bladder incontinence, and autonomic disturbances. Spinal scoliosis is present in 
66% of people with FA and can become pronounced requiring bracing or surgery. 
Diabetes occurs in 30% of individuals with FA and many more have impaired glucose 
tolerance. Hypertrophic cardiomyopathy, defined as an increased thickness of the 
interventricular septum, is present in 66% of people with FA (Delatycki et al., 1999). 
Cardiac changes can also include increased left ventricular wall thickness and 
increased left atrial diameter, all leading to inefficient cardiac function and impaired 
aerobic capacity (Maring et al., 2007).  
Typical FA presents prior to the age of 25 years, with the average age of onset in 
the early to mid-teen years (Delatycki et al., 2012). There are two main types of atypical 
FA: FA with retained reflexes and late onset FA (LOFA). Late onset FA is found in 14% 
of individuals with this disease and is defined as symptom onset after 25 years of age        
(Delatycki et al., 2012). Disease progression is usually slower in LOFA than in typical 
FA with later age of confinement to a wheelchair and a lower incidence of 
musculoskeletal abnormalities (Lynch et al., 2006). The rate of progression in typical FA 
is variable with the average time from symptom onset to wheelchair dependence 
approximately ten years and the average age of death at about 37 years of age. Death 
is usually due to progressive cardiomyopathy or aspiration pneumonia (Maring et al., 
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2007).  Involvement of the spinal cord dorsal columns, spinocerebellar and corticospinal 
tracts and the cerebellar dentate nuclei contribute to the neurological sequelae of FA, 
and it is likely that the sensory neuropathy contributes to the disability observed in these 
individuals (Morral et al., 2010).   
 
Clinical Rating Scales  
Recently, there has been a focus on the development of effective clinical rating 
scales for FA. Clinical trials require valid methods to assess how people with FA change 
over time or how they respond to treatment interventions (Friedman, 2010). The 
International Cooperative Ataxia Rating Scale (ICARS) and the Friedreich’s Ataxia 
Rating Scale (FARS) are two clinical rating scales most commonly used to evaluate 
disease severity and progression in people with FA (Delatycki, 2009). Although the 
Scale for the Assessment and Rating of Ataxia (SARA) was originally developed to 
assess people with Spinocerebellar Ataxia (SCA), it has begun to be used to assess 
people with FA (Delatycki, 2009). Many of the rating scales utilized in FA have not been 
developed using rigorous psychometric assessment methods (Delatycki, 2009). Most 
scales are scored based on examination of a patient’s abilities by a trained evaluator, 
which could limit reliability and sensitivity. The Berg Balance Scale is a valid and reliable 
test of static and dynamic balance which has been tested for validity and reliability in the 
elderly and other neurological populations but not in FA.  
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International Cooperative Ataxia Rating Scale 
The ICARS is a clinical rating scale developed by a committee of the World 
Federation of Neurology for use in clinical trials of cerebellar ataxia (Trouillas et al., 
1997). It is a 100 point, semi-quantitative scale which includes 19 items divided into 4 
unequally weighted sub-scales: posture and gait disturbance (7 items, 34 points); limb 
ataxia (7 items, 52 points); dysarthria (2 items, 8 points); and oculomotor disorder (3 
items, 6 points) (Saute et al., 2011; Storey et al., 2004). A higher score is indicative of 
more severe ataxia. The ICARS has been found to have high inter-rater reliability in a 
study in which 3 neurologists independently assessed videotaped examinations of 
patients with FA or SCA (Storey et al., 2004). The psychometric properties of the ICARS 
were also assessed in a study of 77 people with FA (Cano et al., 2005). Results showed 
that the total ICARS score satisfied all psychometric properties including validity and 
reliability. The posture and gait sub-scale also performed well, yet the other three sub-
scales did not pass the tests of validity or reliability (Cano et al., 2005). These authors 
concluded that although the ICARS total score satisfied basic psychometric tests, its 
validity as a measure of overall ataxia severity or change over time in FA is uncertain. A 
longitudinal study showed the ICARS to have a significant ceiling effect when used to 
examine neurologic and cardiac changes over time in people with FA (Ribai et al., 
2007). These authors concluded that qualitative clinical rating scales such as the ICARS 
were not appropriate to follow neurologic progression over long disease durations. They 
suggested the use of more quantitative measures, which can be used in addition to the 
ICARS.  
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Friedreich’s Ataxia Rating Scale 
The Cooperative Ataxia Group developed the FARS (Subramony et al., 2005) as 
a measure of disease severity in FA. The FARS has a maximum score of 159 points 
with higher score denoting more severe disease. The FARS includes three sub-scales: 
functional staging for ataxia (6 points); activities of daily living (ADL) (36 points); and the 
neurological exam (117 points). The neurologic exam sub-scale comprises bulbar (11 
points), upper limb coordination (36 points), lower limb coordination (16 points), 
peripheral nervous system (26 points), and upright stability and gait functions (28 
points). Functional performance measures have been added to the FARS (referred to 
as FARS IV) and include the nine hole peg test, timed 25 foot walk test, and the PATA 
rate; the number of times the word “PATA” can be repeated and recorded in 10 
seconds. The nine hole peg test is a test of upper limb coordination and speed and the 
timed 25 foot walk test is a gait assessment using a timed walk of 50 feet (25 feet each 
way), which can be completed with or without a gait assistive device.  
Subramony and colleagues (2005) developed and first tested the psychometric 
properties of the FARS in a small study of 14 subjects with FA. They found the FARS to 
have excellent inter-rater reliability with an inter-class correlation coefficient (ICC) of 
0.95 for the total neurological exam score. Excellent inter-rater reliability with high ICC 
was also shown for disease stage, ADL, upper limb coordination, lower limb 
coordination, upright stability and gait, total neurological exam score, PATA rate, nine 
hole peg test, and timed 25 foot walk test. Bulbar (0.29) and peripheral nerve (0.74) 
items showed less inter-rater reliability (Subramony et al., 2005). A larger study 
assessed 155 people with FA and found that FARS scores, performance measure 
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scores and performance measure composite scores (FARS IV) correlated with disease 
duration, functional disability, ADL, and with quality of life measures (Lynch et al., 2006). 
These authors concluded that their results support the validity of the FARS and 
functional performance tests as clinical measures of FA disease progression. In a 
longitudinal study of 43 people with FA, the FARS was compared with the ICARS, the 
Functional Independence Measure (FIM) and the Modified Barthel Index (Fahey et al., 
2007). The FARS was highly correlated with the other three measures. The FARS, 
ICARS and FIM, but not the Modified Barthel Index, were able to show FA disease 
progression over 12 months. The results showed a mean worsening on the FARS of 
9.5/159 points with an effect size of 0.34.  Based on effect size and power analysis, 
these authors concluded that the FARS may be the best scale to use in clinical trials of 
FA (Fahey et al., 2007). Another study reported on disease progression in 168 people 
with FA after 12 and 24 months (Friedman, 2010). These authors concluded that FARS 
total scores and functional composite measures capture FA disease progression, but 
with greater sensitivity to change after two years compared to one year (Friedman, 
2010).   
 
Scale for the Assessment and Rating of Ataxia 
The SARA was developed to measure severity of ataxia and was validated for 
use with people with autosomal dominant SCA (Schmitz-Hubsch et al., 2006). The 
SARA has only eight items with the total score ranging from 0 (no ataxia) to 40 (most 
severe ataxia). The eight items include gait (8 points), stance (6 points), sitting (4 
points), speech disturbance (6 points), finger chase (4 points), nose to finger test (4 
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points), fast alternating hand movements (4 points), and heel-shin slide (4 points). The 
last 4 items (Items 5 through 8) are called limb kinetic functions in which the left and 
right limbs are scored separately, averaged together, and then included in the total 
score. The internal consistency of the SARA was studied in a large European multi-
center trial (Schmitz-Hubsch et al., 2006). The SARA showed very high inter-rater 
reliability, with an ICC of 0.98. Most individual test items also showed good inter-rater 
reliability with ICCs > 0.80. Test-retest reliability was high with an ICC of 0.90 and 
internal consistency was also high. The total SARA score increased with disease stage 
(p<0.001) and was correlated with the Barthel Index (r=0.80) and the functional 
assessment sub-scale of the Unified Huntington’s Disease Rating Scale (r=0.89), 
however, the SARA showed weak correlation with disease duration (r=0.34) (Schmitz-
Hubsch et al., 2006). These authors concluded that the SARA was a valid and reliable 
measure of ataxia and was appropriate for use in clinical trials. Burk and colleagues 
(2009) tested the validity and reliability of the SARA for use in FA. Ninety six subjects 
with FA were rated using three different clinical rating scales: the FARS, ICARS and 
SARA. The SARA showed an ICC of 0.99, internal consistency for each individual test 
item of 0.89, and all items demonstrated high construct validity (Burk et al., 2009). The 
SARA was highly correlated with the ICARS (r=0.953) and FARS (0.938) total scores. 
The total SARA score also correlated with ADLs (r=0.929) and with disease duration 
(r=0.712). The SARA may be used more in future studies of FA as it is considered valid 
and reliable as well as quick and easy to administer (Delatycki, 2009).  
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Berg Balance Scale 
Balance impairments are common sequelae of FA and yet there are no 
standardized assessments which have been validated to strictly assess balance in this 
population. The clinical rating scales reviewed include balance items, however, none of 
these scales focus on balance assessment. The Berg Balance Scale (BBS) is a 14 item 
test that was developed originally to assess static balance and falls risk in the 
community dwelling elderly (Berg, 1989; Berg et al., 1995; 1992). The test is easy and 
takes only about 20 minutes to administer requiring minimal equipment. The items on 
the BBS were developed to evaluate a person’s ability to maintain their position, adjust 
their position during active movements, and respond to external inputs (Datta et al., 
2009). The BBS items are in order of increasing difficulty by either decreasing the base 
of support, moving from sitting to standing, or standing on one leg to step up onto a 
stair. The psychometric properties of the BBS have been tested in the community 
dwelling elderly and those with stroke, spinal cord injury and multiple sclerosis and it 
has been found to be a highly valid and reliable tool for use with these populations 
(Berg et al., 1995; 1992; Blum et al., 2008; Cattaneo et al., 2007; 2006; Mao et al., 
2002; Wirz et al., 2009). The BBS is commonly used among physical therapists to 
assess balance in neurological populations.  The BBS has been used in intervention 
studies with patients with spinocerebellar ataxia, sporadic olivopontocerebellar atrophy 
and sensory ataxia (Ilg et al., 2009; Landers et al., 2009; Missaoui et al., 2013; Riva et 
al., 2014). However, it has not been investigated for assessment of balance in people 
with FA.  
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More research is needed to identify valid and reliable measures of FA disease 
progression that permit clinical trials of therapeutic agents and interventions to be 
conducted within a reasonable period of time.  With the expense of clinical trials and the 
difficulty in recruiting people with FA, measurement tools that enable properly powered 
trials with as few subjects as possible in as short a time frame as possible need to be 
developed further and validated (Delatycki et al., 2012). Although the clinical rating 
scales reviewed are widely used, they do not quantitatively identify balance deficits and 
gait deviations characteristic of ataxia. 
 
Postural Control in Ataxia   
People with FA have postural control and gait impairment that contribute to their 
loss of functional ambulation. Impaired postural control is considered a hallmark of 
ataxia. Postural control involves controlling the body’s position in space for dual 
purposes of stability and orientation (Shumway-Cook et al., 2007). A person must 
maintain an appropriate orientation between their body and body segments in relation to 
the environment to avoid loss of balance and falls. Balance is the ability to control one’s 
center of mass (COM) in relationship to the base of support (BOS) in any given sensory 
environment (Shumway-Cook et al., 2007). Center of pressure (COP) is the average of 
total forces applied by the individual onto the support surface on which the person is 
standing. Researchers use center of mass and center of pressure interactions to study 
the efficacy of postural control.  The most common method used to record displacement 
of the center of pressure is called dynamic posturography, which involves subjects 
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standing on a force measuring platform. Two common parameters tested are postural 
sway and LOS.  
Motor and sensory systems are essential to postural control.  Motor components 
of balance include, for example, organization of muscles into neuromuscular synergies 
and righting and equilibrium reactions. The three primary peripheral sensory inputs 
contributing to postural control are bilateral receptors of the somatosensory, visual and 
vestibular systems. Somatosensation is the dominant sense for upright postural control 
and is responsible for initiating automatic postural reactions. Somatosensory receptors 
located in skin, joints, ligaments, and muscles provide information about muscle length, 
stretch, tension, and contraction, as well as pressure and joint position. The feet, 
ankles, knees, hips, back, neck and eye muscles all provide sensory information useful 
for maintenance of balance. Disease of, or damage to, any part of the peripheral 
sensory receptors and peripheral nerves impairs the detection abilities of this system, 
making sensory information unavailable for use in postural control which can affect 
standing balance.  
There is evidence that increased postural sway and decreased LOS are 
indicative of balance impairment in individuals with disorders such as FA, chronic 
alcoholism and diabetic peripheral neuropathy (Diener et al., 1984; Emam et al., 2009; 
Mauritz et al., 1979; Sullivan et al., 2010). In normal, healthy individuals, there is a small 
amount of body sway (movement of the COM around the BOS) in quiet standing. This is 
called postural sway. Cerebellar damage typically results in increased standing postural 
sway especially with eyes closed (Diener et al., 1984; Mauritz et al., 1979). Mauritz and 
colleagues (1979) noted increased postural sway in individuals with cerebellar atrophy 
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due to chronic alcoholism and they reported that the type of sway was specific to the 
location of the primary cerebellar lesion. Subjects stood on a force platform which had 
strain gauges at each corner to measure the displacement of the COP in the anterior-
posterior and medial-lateral directions, first with eyes open then with eyes closed. 
Individuals with anterior cerebellar lobe atrophy had increased COP movement in an 
anterior-posterior direction only, while those with vestibulocerebellar involvement 
showed postural sway in all directions (Mauritz et al., 1979). Another study confirmed 
these results and found differing patterns of sway abnormality in five groups of subjects 
with ataxia compared with healthy, control subjects (Diener et al., 1984). The postural 
sway patterns were specific to the type of ataxia and the area of the cerebellum 
involved. One group consisted of 8 individuals with FA, referred to as “a disorder of 
spinocerebellar afferents,” who all had loss of vibration and position sense in the lower 
extremities. The subjects with FA showed a stronger lateral postural sway component 
as compared to those with anterior lobe atrophy who showed more anterior/posterior 
sway (Diener et al., 1984). Both groups showed a strong reliance on vision to maintain 
their balance.  Another study by Diener and colleagues (1984) demonstrated that 
people with FA, who had degeneration of spinocerebellar pathways, had a significantly 
increased latency of EMG responses in the tibialis anterior muscle following a forward 
perturbation of the force platform on which they were standing. The tibialis anterior 
muscle should contract eccentrically to control the backward movement of the body as 
the force platform moves forward (Horak et al., 1994; 1989).  However, the individuals 
with FA were unable to control the backward movement of their body as the platform 
moved forward.  
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People with chronic alcoholism exhibit peripheral neuropathy and cerebellar 
vermian volume loss, which contribute to their balance deficits and gait ataxia even after 
months of sobriety. Alcoholic women exhibited greater postural sway path length than 
control subjects and sway in the anterior-posterior direction was greater than in the 
medial-lateral direction (Sullivan et al., 2010). Despite significant postural sway in 
alcoholics, they can use visual and tactile cues and stance stabilizing conditions to 
significantly lesson their postural sway (Sullivan et al., 2006, 2010). People with diabetic 
sensory neuropathy show poor postural control and are at a much higher risk to fall. 
This has been attributed to their lack of accurate proprioceptive feedback from the lower 
limbs (Emam et al., 2009). Emam and colleagues (2009) evaluated postural stability 
using dynamic posturography in a group of Type 2 diabetics with peripheral neuropathy 
compared to a group of diabetics without neuropathy. They concluded that postural 
instability in diabetics with peripheral neuropathy reflects impairment of the 
somatosensory system and that early detection of imbalance may predict and help 
prevent falls in people with lower extremity somatosensory loss. People with FA have 
somatosensory and proprioceptive deficits due to involvement of peripheral nerves, the 
dorsal root ganglia and the spinal cord, which may contribute to increased postural 
sway in standing and subsequent balance deficits.  
Any given base of support puts limits on the distance a person’s body can move 
without either falling (as COG exceeds BOS) or establishing a new BOS by stepping 
with one foot (to relocate BOS under COG). This perimeter is often called the LOS. 
Limits of stability has been defined as “the farthest distance in any direction a person 
can lean (away from midline) without altering their original BOS by taking a step, 
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reaching with outstretched arm or falling” (Umphred, 2007). Mohan and colleagues 
(2009) used the Biodex Balance System SD (Biodex Medical Systems, Inc., NY) to 
assess postural stability and LOS in people with spinocerebellar ataxia type 1 (SCA1). 
Postural stability was assessed by testing subject ability to control balance in all 
directions [Overall Stability Index (OSI)], front to back [Anterior-Posterior Index (API)], 
and side to side [Medial-Lateral Index (MLI)]; and their ability to control LOS in all 
directions. Impaired balance was found in 80% of people with SCA1 (all indices were 
impaired in 35% of subjects, OSI and API in 25%, only OSI in 15%, and OSI plus MLI in 
just 5%). Compared to controls, people with SCA1 had significantly higher postural 
stability indices and lower LOS scores, indicative of worse balance. The mean value of 
API was significantly higher than MLI. Only 14 of 20 subjects with SCA were able to 
complete the LOS task and those who did took significantly longer to complete the task 
and had significantly lower scores than controls. These authors also reported that all 
balance indices were significantly correlated with ICARS scores.  
 
Gait in Ataxia 
Balance deficits, including increased postural sway and decreased LOS, have 
been shown to be related to gait ataxia (Morton et al., 2003; Morton et al., 2004, 2007). 
Worsening gait ataxia can contribute to falls and loss of functional ambulation. Morton 
and Bastian (2003) found that subjects with severe balance deficits but without leg 
coordination deficits demonstrated all of the classic features of gait ataxia including 
decreased gait velocity and stride length, increased stride width, increased variability in 
foot placement, and increased stride to stride variability in joint angles as compared with 
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subjects who had primarily leg placement deficits. These authors concluded that 
balance deficits contribute much more strongly to gait ataxia than lower extremity 
incoordination (Morton et al., 2003; Morton et al., 2004, 2007).  
Cerebellar ataxic gait is characterized by unsteadiness, staggering, a veering 
path of movement, variable foot placement, and abnormal inter-joint coordination 
patterns (Morton et al., 2004). This gait pattern, a hallmark of ataxia, has been widely 
studied and described (Earhart et al., 2001; Ilg et al., 2007; Morton et al., 2003; Morton 
et al., 2004, 2007; Palliyath et al., 1998). Ataxic gait has been studied quantitatively 
using motion analysis systems, stride analyzers and more recently using the GAITRite 
Walkway System (CIR Systems, Inc., PA). Palliyath and colleagues (1998) studied the 
gait pattern of 10 subjects with cerebellar degeneration compared with 10 healthy, 
control subjects using a five-camera, kinematic and kinetic data acquisition system. This 
type of motion analysis provides detailed information about joint motion and forces of 
the body during walking, yet, the equipment is costly and data collection is time 
consuming. The GAITRite Walkway system is a valid and reliable tool used to measure 
spatial and temporal parameters of gait (Bilney et al., 2003). This system has been 
tested for reliability in neurological conditions including Parkinson’s disease, 
Huntington’s disease, stroke and cerebral palsy (Kuys et al., 2011; Nelson et al., 2002; 
Rao et al., 2005; Wondra et al., 2007).  The GAITRite Walkway system allows for 
determination of gait parameters such as velocity, cadence, step and stride length, and 
percent of the gait cycle in single and double limb support, yet, the system is portable 
and the data can be collected in a relatively short period of time. 
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Walking speed, also called gait velocity, is a valid, reliable, sensitive and specific 
measure that correlates with balance, functional abilities and falls risk (Fritz et al., 
2009). Individuals with FA often lose the ability to walk in early adulthood and declining 
gait velocity may predict functional decline. But why is gait speed a good predictor of 
function? Walking is a complex task requiring significant energy. Many variables can 
affect a person’s walking speed including motor control, muscle strength, sensation and 
endurance. Additionally, walking places demands on many body systems including the 
heart, lungs, circulatory, nervous and musculoskeletal systems (Studenski et al., 2011). 
People with FA show involvement of many of these systems and the disease affects 
energy production at the cellular level. Community ambulation involves more than how 
fast a person walks. Decreased step and stride length are also seen in ataxic gait and 
contribute to decreased gait velocity (Earhart et al., 2001; Ilg et al., 2007; Morton et al., 
2003; Palliyath et al., 1998). People with FA have balance and coordination problems 
that predispose them to falls. They may limit their step length and limit community 
ambulation or use a wheelchair to avoid falls which will secondarily affect their 
endurance.  
Gait variability has also been well documented in ataxia and is related to 
functional walking impairment (Ilg et al., 2007; Morton et al., 2003; Palliyath et al., 
1998).  Palliyath and colleagues (1998) found that subjects with cerebellar degeneration 
showed significantly reduced step and stride lengths and a trend toward decreased 
cadence which both contributed to slower gait velocities. Subjects with ataxia showed 
significant variability of nearly all gait parameters including step and stride length, 
cadence, step time and stance time. These authors concluded that although gait 
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variability is characteristic of movement disorders, it is particularly marked in cerebellar 
dysfunction. Stolze (2002) analyzed gait ataxia in twelve subjects with cerebellar 
disease of various causes compared to twelve age-matched controls using a motor 
driven treadmill and motion analysis. They reported significantly reduced step frequency 
with prolonged stance and double limb support duration in the people with cerebellar 
disease. Most gait parameters were found to be highly variable in this population and 
the balance related variables such as step width and foot rotation angle were increased 
in the cerebellar group indicating a need for stability during locomotion. Cadence was 
reduced as a result of increased stance and double limb support duration, which may 
have been another compensation developed to make walking more stable (Stolze et al., 
2002).   
Researchers investigated the effect of different types of cerebellar dysfunction on 
the gait pattern of people with cerebellar degeneration using motion analysis and the 
ICARS (Ilg et al., 2007). They found significant differences between subjects with 
cerebellar degeneration and healthy controls in several gait parameters including step 
length, step width, gait velocity and step length variability. Consistent with other studies 
(Morton et al., 2003; Palliyath et al., 1998; Stolze et al., 2002), Ilg et al. (2007) found a 
high correlation between balance related gait parameters and balance deficits as 
measured by a subscore of the ICARS clinical rating scale. Additionally, a comparison 
of gait measures between three groups of subjects with different movement disorders 
(cerebellar degeneration, Parkinson’s disease and peripheral vestibular disease), 
indicated that increased temporal variability of intra-limb coordination patterns was 
specific to cerebellar degeneration and not an indirect consequence of balance 
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problems. Morton and colleagues (2010) conducted a one year longitudinal study of gait 
and balance changes in eighteen subjects with mixed cerebellar disorders including 
tumor, stroke and degenerative disease using motion analysis, a balance force plate 
and the ICARS test. Subjects were assigned to three groups: a group with static, 
unchanging cerebellar lesions; a degenerative cerebellar group; and a healthy, control 
group. There were significant differences in postural sway and gait parameters 
(including stride length, stride width, cadence, stance time, double-support time and gait 
velocity) between the cerebellar groups and the control group. Neither cerebellar group 
demonstrated significant changes in postural sway, sway variance or dynamic weight 
shifting over one year. However, over time, the static group tended to walk faster and 
take longer strides while the degenerative group walked slower and took shorter strides. 
There was a significant worsening of ICARS scores in the degenerative group over one 
year as compared to the other two groups. These researchers concluded that the 
ICARS test was sensitive to increases in ataxia severity occurring over time and it 
correlated well with the instrumented measures of gait (Morton et al., 2010).  
Less well understood is the gait pattern of individuals with a sensory ataxia such 
as FA. Croarkin and Maring (2009) described gait parameters in 38 children and 
adolescents with FA and examined the relationship between disease severity, as 
measured by the FARS test, and gait parameters. Spatiotemporal gait parameters were 
collected using a computerized footswitch system and compared with age-matched 
normative data. Adolescents and children with FA showed significantly slower gait 
velocity, reduced cadence and shorter stride lengths compared with children without 
disabilities. These gait parameters were strongly correlated with FARS scores and the 
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scores were predictive of the children’s level of walking ability. Serrao and colleagues 
(2012) studied the gait pattern of 8 subjects with SCA and 8 with FA using motion 
analysis and force plates to record kinematic and kinetic data, respectively. They found 
a marked difference in all gait parameters between subjects with ataxia and healthy 
controls. They also reported a strong correlation between stride length and stance 
duration and ICARS scores (gait, posture and total scores). Both ataxic groups 
demonstrated wide based walking with increased double support time, increased stance 
duration, decreased step length and decreased gait velocity compared with healthy 
controls. People with FA exhibited shorter step lengths than those with SCA. For almost 
all gait parameters, there was significant intra-subject gait variability in those with ataxia 
compared to controls, which was strongly correlated with ICARS scores. Other 
researchers evaluated gait variability in 31 subjects with FA across age groups using a 
gait variability index (GVI) and reported the GVI to be significantly lower in the FA group 
compared to the control group, indicative of greater variability (Gouelle et al., 2013).  
Ilg and colleagues (2009) examined the effectiveness of a four week intensive 
coordination training program for 16 patients with progressive ataxia due to either 
cerebellar degeneration (n=10) or degeneration of afferent pathways (n=6). This latter 
group with sensory ataxia included 3 people with FA. The primary outcome measures 
included the SARA, ICARS, BBS, subject perceived goal attainment and quantitative 
balance and gait analysis using an 8 camera motion analysis system. They examined 
gait velocity, step length, step width, lateral body sway and temporal variability of intra-
limb coordination during walking. They also determined body sway in standing by 
measuring movement of the COG during a static and a dynamic balance task. Four 
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assessments were performed at 8 weeks before, immediately before, directly after and 
8 weeks after training. The results revealed a significant decrease in ataxia symptoms 
for all subjects as measured by the SARA following a 4 week coordination training 
program. Patients with predominantly cerebellar ataxia showed a more distinct 
improvement than those with sensory ataxia in gait velocity, lateral body sway, intralimb 
coordination and static and dynamic balance tasks. Follow-up assessment at 8 weeks 
showed retention of improvement in the cerebellar group but not the afferent group for 
all tasks except the dynamic balance task. Ilg and colleagues (2010) went on to assess 
the same subjects one year after the 4 week intensive coordination training program. 
Despite a gradual decrease in motor performance and increase in ataxia due to disease 
progression in both patient groups, improvements in motor performance and ADL 
persisted after 1 year in the cerebellar group after 4 weeks of intensive coordination 
training. For the afferent group, the improvement in ataxia symptoms were less 
pronounced and did not persist at 1 year follow-up.  
 
Summary  
In summary, research investigating FA balance and gait is very limited. One 
study characterized gait patterns in children and adolescents with FA (Croarkin et al., 
2009). Two studies investigated gait in subjects with FA across age groups; one 
comparing gait in people with FA to that of SCA, while a second study focused on the 
use of a gait variability index (Serrao et al., 2012; Gouelle et al., 2013). Most research 
studies of balance and gait in ataxia use cross sectional research designs and clinical 
rating scales, such as the ICARS, FARS and SARA, but these scales are subject to 
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bias. Although these clinical rating scales are widely used, they do not quantitatively 
identify balance deficits and gait deviations characteristic of ataxia. Some cross 
sectional studies have used force platforms and motion analysis to quantitatively 
measure balance and gait, respectively. Cross sectional studies cannot measure 
change in balance and gait over time as is possible with a longitudinal research design. 
To our knowledge, only one longitudinal, natural history study has investigated change 
in balance and gait over time, but this study included people with mixed cerebellar 
disorders and no subjects with FA (Morton et al., 2010). Recently, quantitative tools 
such as the Biodex Balance System SD (Biodex Medical Systems, Inc., NY) and the 
GAITRite Walkway System (CIR Systems, Inc., PA) have become available to 
objectively assess balance and gait, respectively. Studies using clinical rating scales 
have shown that 1 to 2 years is not long enough to show minimally important 
differences in FA disease progression (Cano et al., 2005; Ribai et al., 2007). It is 
possible that quantitative measures of gait and balance could show more subtle 
changes in shorter periods of time.  
Quantitative analysis of FA balance and gait is quite limited, with no study 
investigating the natural history and progression of both balance and gait deficits in 
adults over time. Little evidence exists as to which methods are most sensitive for 
tracking the progression of FA balance and gait, but this information is critical for 
assessing the effectiveness of current and newly developing treatments. Such 
information is also important to plan and assess the efficacy of rehabilitation strategies 
and to predict risk of falls and future level of walking ability.  
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The purpose of the present study was to characterize the gait pattern of adults 
with FA and to determine whether gait parameters change over 24 months. This study 
also investigated whether postural control; postural stability and limits of stability, and 
BBS scores change over 24 months in this patient cohort. Finally, the study investigated 
the relationship between disease duration, clinical rating scale scores and objective 
measures of gait and balance.   
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CHAPTER TWO 
METHODS 
 
Research Design 
This study used a longitudinal research design to investigate changes in balance 
and gait over time in adults with FA. The study and all research procedures conducted 
as part of this study were approved by the University of South Florida (USF) Institutional 
Review Board (#Pro00001687).  
 
Study Participants  
Subjects for this study included eight adults with genetically confirmed FA and 
eight healthy, matched controls. Control subjects were matched based on gender, age, 
height and weight and had no history of neurodegenerative or musculoskeletal disease 
that would affect their gait or balance.  The criteria used to match controls to cases were 
pre-established within the following parameters: same gender, age (±3 years), height 
(±5 cm) and weight (±10 kg).  All subjects gave informed consent using an IRB 
approved consent form prior to participation in this study. Subjects with FA were 
recruited from the USF Neurology clinics, from local and state ataxia support groups, 
and nationally from the Friedreich’s Ataxia Research Alliance (FARA). Control subjects 
were recruited from among the students, faculty and staff of USF Health and from the 
community.  
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Inclusion and Exclusion Criteria  
The following criteria were met for subjects to participate in this study: diagnosis 
of FA confirmed by genetic testing (cases only); subjects between 18 and 50 years of 
age; subjects must be taking stable doses of all prescription and over-the-counter 
medications for 30 days prior to study entry and for the duration of the study; subjects 
could not enroll in any drug or other intervention trials during the course of this study; 
and subjects had to be able to ambulate with or without an assistive device for at least 
30 feet and maintain stable levels of physical activity and exercise. 
The following criteria excluded subjects from participating in this study:  presence 
of neurodegenerative disease (controls only); presence of any condition resulting in a 
disturbance of gait or balance (controls only); any unstable illness that in the 
investigator’s opinion precluded participation in this study such as advanced 
cardiopulmonary disease, dementia or other psychiatric illness; legal incapacity or 
limited legal capacity; or women who were pregnant or breast feeding.  
 
Study Procedures  
All subjects received a comprehensive examination in the USF Department of 
Neurology which included history, neurological examination and the FARS. Gait and 
balance were tested quantitatively using equipment in the USF School of Physical 
Therapy and Rehabilitation Sciences Human Functional Performance Laboratory. This 
equipment allowed for serial objective measurement of gait and balance parameters. 
The Berg Balance Scale (BBS) was conducted to assess static and dynamic balance. 
Subjects with FA underwent evaluation of gait and balance and clinical rating scales at 
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baseline, 6 month, 12 month and 24 month follow-up. Matched control subjects 
underwent the same testing, but only at baseline and 12 months.  
 
Clinical Rating Scales 
All subjects rated their perceived exertion (RPE) (Borg et al., 1982) and vital 
signs (blood pressure and pulse) were measured and recorded immediately before and 
after gait and balance tests. The Borg RPE Scale uses a psychophysiologic approach in 
which the exerciser rates their feelings of perceived exertion related to strain, discomfort 
and/or fatigue experienced during aerobic or resistance exercise. The RPE scale is a 
numerical scale from 6 to 20 in which 6 equals no exertion at all while 20 equals 
maximal exertion. Subjects were rated by a neurologist on the FARS, a test of disease 
severity using an ordinal rating scale. The neurological exam subscale measures bulbar 
and speech function, upper and lower extremity coordination, peripheral neuropathy, 
and upright stability. Lower extremity sensory testing was conducted as part of the 
neurological exam. Subjects were also assessed by a physical therapist on the BBS, a 
valid and reliable test of static and dynamic balance consisting of 14 tasks (Berg et al., 
1992). This balance scale requires participants to perform various tasks in sitting and 
standing, for example, sit to stand, standing unsupported, and reaching with 
outstretched hand while standing. Each item is graded on an ordinal scale from 0-4 with 
a maximum total score of 56. People who score below 45 out of 56 are considered at 
greater risk to fall (Berg et al., 1992).  
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Gait Testing Procedures 
Spatiotemporal gait parameters were quantified using the GAITRite Walkway 
System (Figure 2). This system is a computer based instrumented walkway developed 
to measure gait and includes a 26 foot long by 3 foot wide mat (7.93 X 0.91 meters) 
which resembles a carpet runner. An extensive array of electronic pressure-activated 
sensors is imbedded in the 1/8” thick mat between a carpet layer on top and foam 
rubber on the bottom. The sensors are arranged in a grid pattern and placed 1.27 cm 
apart with a total of approximately 14,000 sensors. These sensors are activated by 
mechanical pressure at foot contact as the person walks down the mat. Data is sampled 
from the mat at a frequency of 80 Hz. Data are collected from activated sensors by a 
series of processors (located on one side of the mat) and uploaded to a laptop 
computer through a serial port. Dedicated GAITRite application software (Version 4.7) 
converts the raw data into footfall patterns and computes temporal parameters such as 
gait velocity or time in double limb support, and spatial parameters such as step and 
stride length. The software program calculates gait parameters for each footstep of 
each walking trial as well as an overall average of all trials for each parameter. The 
following gait parameters were evaluated in this study: gait velocity (m/s), cadence 
(steps/min), step length (cm), stride length (cm), step and stride length variability (cm) 
and percent of the gait cycle in swing, stance and double limb support.   
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Figure 2. GAITRite Walkway System 
Photos courtesy of GAITRite Walkway Systems, Inc.   
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Subjects were allowed to walk down the GAITRite mat using their usual gait 
assistive device. The data processing software eliminated strikes from assistive devices 
so that only footstep data was saved. Walking performance was recorded using a digital 
videocamera, which was set up on a tripod approximately 6 feet from the end of the mat 
to capture each subject’s walking trials for the entire length of the walkway. The video 
was used to verify subject identity, assistive device use, level of assist required to walk 
and to verify walking parameters related to data processing. The video was also used 
along with the software to confirm the number of footsteps in each trial and that the 
footsteps were completely on the mat. Data generated from each trial was checked to 
assure that this trial represented gait performance consistent with other trials in the 
same test.  
The height, weight and bilateral leg length for each subject were measured prior 
to baseline gait testing. Subject leg length was measured as the distance (in cm) from 
the greater trochanter to the floor bisecting the lateral malleolus. This information was 
entered into the computer to enable the GAITRite software to calculate gait parameters. 
The subjects were asked to walk along the 26 foot long walkway for five trials at their 
comfortable, self-selected walking speed. They were then asked to walk at their fastest 
possible speed with verbal instruction to “walk as fast as you can.” The comfortable and 
fast walking trials were each preceded by one practice trial. Subjects began walking 
about 2 meters before the mat and continued walking about 2 meters past the end of 
the mat. This assured that they walked at a consistent speed along the instrumented 
section of the mat. Subjects were encouraged to wear the same (or similar) pair of flat 
soled shoes for each testing session. The subjects were supervised closely by a 
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licensed physical therapist during walking tests. Each subject wore a gait belt so that 
the therapist could grasp hold of them in the event of a loss of balance while walking.  
 
Gait Data Processing  
 While all spatiotemporal gait parameters captured by the GAITRite Walkway 
System were collected, processed and analyzed, the focus of data analysis was on gait 
velocity, cadence, step and stride length, step and stride length variability and percent 
of the gait cycle spent in swing and stance phase and double limb support. Gait velocity 
was calculated by dividing the distance walked by the ambulation time expressed in 
m/s. Ambulation time is the time elapsed in seconds between the first contact of the first 
footfall to first contact of the last footfall on the mat. The GAITRite software forms a 
quadrilateral shape around each footprint for each walk and uses this information to 
calculate the heel center of each footprint. The line of progression is the line connecting 
the heel centers of two consecutive footfalls of the same foot. Step length was 
measured on the horizontal axis of the GAITRite walkway from the heel center of one 
footprint to the previous footprint of the opposite foot expressed in cm. Stride length was 
measured on the line of progression from the heel centers of two consecutive footprints 
of the same foot expressed in cm. Variability of step and stride lengths were determined 
by calculating standard deviation of step or stride length over the five trials for 
comfortable and fast walking separately.  Variability was calculated as the standard 
deviation of step or stride length utilizing the formula:   
  √
 
    
∑(    ) 
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Following each walking trial, data were uploaded to the computer and automatic 
footstep identification and gait parameter calculations were made by the GAITRite 
software. The GAITRite system automatically provided quantitative data about the 
subject’s walking, however, it also allowed for manual processing of footprints. In this 
study, each footprint and walk was manually processed to assure accuracy and 
consistency of gait data within and across subjects. To manually process the gait data, 
each footprint was identified and separated from the other footprints in the same walk. 
Incomplete footprints at the beginning or end of each walk were removed from the walk. 
Strikes from gait assistive devices or foot scuffs were removed from the walk. Left and 
right footprints were delineated and all footprints separated from each other. Once this 
manual gait data processing was completed, the GAITRite software re-calculated all 
gait parameters and the data for each walk were saved. The data from each walk and 
the averaged data across five trials for both comfortable and fast walking were exported 
to an excel spreadsheet for further analysis. 
 
Balance Testing Procedures 
Subject balance was examined utilizing the Biodex Balance System SD which is 
an instrumented platform developed as a testing and training device appropriate for 
individuals with neuromusculoskeletal disorders (Figure 3). The Biodex Balance System 
SD (Biodex SD) consists of a suspended circular platform with four built-in strain gauge 
type pressure sensors, one in each of four quadrants of the platform. This strain gauge 
technology allows the Biodex SD to detect weight distribution of the subject as they 
stand or sway on the platform. The degree of platform surface instability is controlled by 
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a microprocessor-based actuator; however, for this study the platform remained in the 
locked or static setting for all tests. The platform is connected to computer software 
(Biodex Version 3.1, Biodex Medical Systems, NY) which allows the device to be used 
objectively in posturography. Prior to beginning testing, the age and height category for 
each subject were entered. Subjects were asked to stand comfortably on the platform 
with arms at their sides such that foot placement could be established. A cursor, which 
represents the real time location of the subject’s center of pressure, appeared on the 
visual display. The researcher adjusted the position of the subject’s feet until both feet 
were equidistant from the center of the platform and the cursor remained at the center 
of a series of concentric circles (target). Once the feet were positioned on the platform, 
tape was placed around each foot so that the feet could be repositioned easily should 
the subject move them during testing. Foot placement data were recorded to insure 
consistency for each test and consistency of foot placement in subsequent follow-up 
testing.  
The Biodex SD was used for measurement of postural stability and LOS. Two 
postural stability tests were conducted which are indicative of postural sway. The first  
involved the subject standing quietly with eyes open and hands at their sides, while the 
second involved quiet standing with eyes closed. Subjects were not allowed to view the 
monitor during postural stability tests and three 30 second trials of each test were 
preceded by one practice trial. 
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Figure 3. Biodex Balance System SD 
Photos courtesy of Biodex Medical Systems, Inc.  
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Subjects performed three trials of the LOS test and were allowed to view the 
monitor during this test. For the LOS test, subjects were asked to shift their center of 
pressure to eight targets positioned in an elipse without changing foot position. During 
each trial, subjects shifted their weight to move the cursor from the center target to a 
peripheral blinking target and back to center as quickly but as accurately as possible. 
This process was repeated for each of nine peripheral targets which were set to blink in 
random order. During all tests on the balance platform, subjects wore a gait belt and 
were supervised by two physical therapists. Subjects were allowed to hold onto the 
handrail only to prevent a fall.   
 
Balance Data Processing 
The balance parameters generated by the Biodex SD for the two postural 
stability tests (quiet standing with eyes open and quiet standing with eyes closed) 
included an Overall Stability Index (OSI), an Anterior/Posterior Stability Index (API), and 
a Medial/Lateral Stability Index (MLI). The Biodex SD calculated these parameters as 
indicative of postural sway. Postural sway is commonly measured by recording 
displacement of Center of Pressure (COP) on a force measuring platform 
(posturography). The objective of the postural stability tests is to quantitatively 
determine a score representing a subject’s ability to maintain a stable vertical posture or 
position on the stationary platform under varying sensory conditions; either eyes open 
or eyes closed.  
Subjects stood on the static force measuring platform. The platform contains four 
strain gauge type pressure sensors; one in each of four quadrants. The static balance 
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platform sampled and recorded subject COP movement continually at a sampling rate 
of 20 Hz. The strain gauge sensors detected forces applied downward in each of 4 
quadrants during subject movement in quiet standing. The sensors measured 
displacement of the subject’s center of pressure in an anterior/posterior and 
medial/lateral direction as a measure of postural sway. For example, during increased 
postural sway in an anterior direction, increased force is applied by the subject in the 
anterior quadrant of the platform. The Biodex SD uses this information to calculate 
movement of the COP anteriorly to calculate API. The COP is the subject’s center of 
gravity (COG) projection on the platform resulting from sway angle and patient height. 
Each recorded sample consisted of an (x, y) coordinate. The sway angle was derived 
from the displacement of the COG from zero and the subject’s height with COG taken 
as .55 of each subject’s height. The OSI, API and MLI indices represent measures of 
variance (standard deviation) which were assessed from movement of subject COG 
along a sway path around a zero point representing the center of the platform. 
Displacement of the COG that occurs along the medial/lateral axis is labeled as x-
direction, while that on anterior/posterior axis is labeled as y-direction and these 
variables are used to generate the MLI and API. The OSI, which is sensitive to change 
in body sway in both the M/L and A/P direction was derived from the following formula:   
                         √∑(   )   ∑(   )             
The balance parameters generated by the Biodex SD for the LOS Test included 
an Overall Directional Control Score, time to complete the test, and directional control 
scores for forward, backward, left, right, and combination directions such as forward and 
to the left. Limits of stability are defined as the maximum angle a person’s body can 
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lean away from the vertical without losing balance. Once the LOS is exceeded, a 
corrective strategy like a step must occur to prevent the person from falling. LOS for 
bilateral stance in normal adults is 8 degrees anterior, 4 degrees posterior and 16 
degrees in a lateral direction. The LOS test challenges subjects to control their COG 
within their base of support. During each trial, subjects must shift their weight to move 
the cursor from a center target to a blinking target and back to center as quickly and 
with as little deviation as possible. This same process is repeated for each of 8 
peripheral targets and these targets blink red in random order. One parameter 
calculated by the Biodex SD for the LOS test is time, i.e., how long it takes the subject 
to move the cursor to all 8 peripheral targets and back to the center. The static (non-
movable) platform is used to record subject’s movement of their COG over their base of 
support as an average amount of angular displacement of the COG defined as a 
percentage of the LOS. The Biodex SD calculates the directional control scores by 
dividing the straight line distance from the center target to the peripheral target (in cm) 
by the actual distance traveled (in cm) multiplied by 100 to generate a percentage 
score.  
            Directional Control Score (%) = straight line distance to target   X100 
                                                                  actual distance traveled 
 
 
The overall directional control score for the LOS Test was calculated as an average of 
the directional control scores to all 8 targets. This represents an overall LOS score for 
the subject on this test. 
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Data Analysis 
Subject demographic characteristics and all gait and balance measures were 
summarized using means and either standard deviations or standard error. 
Demographic, gait and balance data were tested for normality using the Shapiro-Wilk 
test. Baseline gait and balance measures were compared between subjects with FA 
and normal, healthy controls. In addition, gait and balance parameters were analyzed to 
identify longitudinal changes in performance for subjects with FA from baseline to 6, 12 
and 24 months. Control subject baseline and twelve month data were used as a normal 
comparison. Statistical analyses were conducted utilizing the Statistical Package for 
Social Sciences version 22.0 (SPSS; IBM Corp; Armonk, NY) and SAS version 9.3 
(SAS Institute, Cary, NC). Paired t-tests were conducted to determine if there was a 
significant difference between FA and control subjects in gait and balance parameters 
and clinical rating scale scores at baseline. Paired t-tests were also conducted to 
assess for differences in control gait and balance measures from baseline to 12 months. 
When a variable’s distribution showed evidence of non-normality, the Wilcoxon Signed 
Rank test was applied in place of the paired t-test.  
Repeated measures analysis of variance (ANOVA) was performed to test mean 
differences in gait and balance data for subjects with FA across three sessions of 
assessments (baseline, 6 month, and 12 month follow-up). The critical assumption of 
repeated measures ANOVA, sphericity, was tested using Mauchly’s method. Because 
this assumption was violated for several variables and due to missing data for one 
subject at the 24 month testing session, a linear mixed effect model was applied to FA 
subject data from baseline to 24 months.  
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Pearson’s Correlation Coefficients were assessed to determine whether there 
were significant linear correlations between age, disease duration, years since FA 
diagnosis and gait and balance parameters at baseline and at 24 months. Spearman’s 
correlation coefficients were assessed to determine whether there were significant 
correlations between BBS and FARS scores (total and upright stability scores) and gait 
and balance parameters at baseline and at 24 months. Additionally, Pearson’s 
correlations were assessed to determine the strength of the linear association between 
quantitative balance and gait parameters at both time points. All statistical tests were 
two sided with significance level set at p<0.05.   
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CHAPTER THREE 
RESULTS 
 
Demographic and Clinical Characteristics 
Subject demographic and clinical data are summarized in Table 1. Subject 
demographic data (age, height, and weight) were measured at baseline. There were no 
significant differences in mean age, height or weight between adults with FA and their 
matched controls as determined using paired t-tests (p>0.05). Six FA subjects had 
symptom onset during adolescence, whereas the remaining two had symptom onset 
during adulthood, thus they had a type of FA referred to as late onset FA (LOFA). All 8 
control subjects completed baseline and 12 month testing sessions, whereas 7 subjects 
with FA completed baseline, 6 month, 12 month and 24 month testing sessions, and 1 
FA subject failed to complete the 24 month testing session. Disease duration among FA 
subjects varied from 6 to 16 years with an average of 10 years. Two subjects with FA 
used an assistive device for household and community ambulation, while 3 others used 
a device for community ambulation only. The FA subject with longest disease duration 
(16 years) was the only one who required a walker during gait testing. No subjects with 
FA wore lower extremity orthotics.   
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Table 1. Demographic and Clinical Characteristics  
 
Subject demographic data (age, height, weight) and clinical characteristics were determined at baseline. Disease duration 
is defined as the time from symptom onset to enrollment in the study. *Genetic information for subject F8 indicated 200-
400 repeats on one allele, with the number of repeats on the other allele within the normal range.  
Subjects 
with FA Sex 
Age 
(years) 
Height 
(cm) 
Weight 
(kg) 
 
BBS 
Scores 
FARS 
Total 
Scores 
Age at 
symptom 
FA onset 
 
Age at  
Diagnosis 
Disease 
Duration 
(years) 
Genetic 
Repeats 
F1 F 34 152.4 56.7 14 66 18 19 16 850/1000 
F2 F 21 154.9 56.7 45 40 13 17 8 933/800 
F3 M 25 172.7 70.3 45 42.5 15 19 10 500/900 
F4 M 25 175.3 101.2 46 42.5 15 19 10 500/900 
F5 M 23 180.3 61.7 44 33 15 15 8 892/533 
F6 M 43 185.4 80.7 50 45 28 30 15 1067/18 
F7 M 42 187.9 106.6 53 29 36 39 6 1000/166 
F8 M 22 185.4 72.6 51 35.5 16 19 6 * 
Mean (sd)  29.4 (9.0) 
 
174.3 (13.8) 
 
75.8 (19.2) 
 
43.5 (12.4) 41.7 (11.2) 19.5 (8.1) 
 
22.1 (8.1) 9.9 (3.8) 
 
 
Control 
Subjects   
 
 
 
 
  
  
 
    
C1 F 37 154.9 56.7 56 1     
C2 F 23 154.9 56.3 56 0        
C3 M 25 172.7 70.3 56 0     
C4 M 24 177.8 95.3 56 0        
C5 M 22 177.8 72.6 56 0        
C6 M 43 185.4 75.8 56 0        
C7 M 41 182.9 104.3 56 0        
C8 M 22 185.4 70.3 56 2        
Mean (sd)  29.6 (9.1) 174.0 (12.5) 
 
75.2 (19) 
 
56 (0) 0.38 (0.7) 
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Baseline Comparisons between FA and Control Subjects   
  As expected, at baseline, there were significant differences in all gait and 
balance parameters and clinical rating scale scores between subjects with FA and their 
matched controls as determined using paired t-tests (p<0.05). All measures were tested 
and found to be normally distributed using the Shapiro-Wilk test.  
 
  Clinical Rating Scales 
Berg Balance Scale scores are presented in Table 1. All control subjects 
achieved the maximum score of 56 on the BBS assessment. One FA subject received a 
score of 14, while values for the other 7 FA subjects ranged from 44 to 53. Thus, 
subjects with FA exhibited significantly lower scores than controls (p<0.05).  Two FA 
subjects had BBS scores of 14 and 44 at baseline which fell below the cut-off score of 
45 considered indicative of falls risk.  
FARS total scores, also shown in Table 1, differed significantly between subjects 
with FA and healthy controls at baseline as determined using paired t-tests (t=10.54, 
p<0.001). In addition, FARS upright stability scores were significantly different between 
groups (t=13.96, P<0.001). The control subjects had near perfect FARS total scores 
and perfect upright stability scores of zero at baseline. In contrast, subjects with FA had   
mean FARS total scores of 41.7 with a range from 29 to 66 and mean upright stability 
scores of 24.9 with a range from 19 to 33. The FARS scores of the FA cohort are 
indicative of ataxia symptoms and the range of scores indicate the heterogeneity of the 
sample.  
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  Gait   
 Table 2 summarizes baseline gait parameters for the FA and control groups. Gait 
velocity in the FA group was approximately 50% slower than the control group during 
both comfortable and fast walking (p<0.001). Cadence was reduced by 30% for 
comfortable walking and 35% for fast walking (p<0.01), while step and stride lengths 
were 32% shorter in the FA group compared to controls during both comfortable and 
fast walking (p<0.001). Step and stride length variability were 3.5- and 2.7-fold greater 
(p<0.01) for subjects with FA than for controls during comfortable and fast walking, 
respectively.  
There was a significant difference between FA and control groups in percent of 
the gait cycle (GC) spent in swing, stance and double limb support for both comfortable 
and fast walking at baseline. Controls spent 39% of the GC in swing phase and 61% in 
stance phase during comfortable walking, whereas subjects with FA spent less time in 
swing phase (34% of GC) and more time in stance phase (66% of GC), differences that 
were significant (p<0.01). Similarly, during fast walking, controls spent 42% of the GC in 
swing phase and 58% in stance phase, while subjects with FA spent 38% of the GC in 
swing phase and 62% of the GC in stance phase (p<0.01). In addition, subjects with FA 
exhibited a prolonged double limb support phase (31% and 23% of the GC during 
comfortable and fast walking, respectively) compared with the control group (22% and 
16% of the GC during comfortable and fast walking, respectively) (p<0.01). 
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Table 2. Baseline Gait Parameters 
 
All values are expressed as means ± SEM. Paired t-tests were used to compare FA to 
control groups at baseline.  
 
 
 
  
FA 
 
Control 
 
p value 
 
 
Comfortable Walking 
   
Velocity (m/s) 0.7 ± 0.1 1.4 ± 0.0 p<.001 
Cadence (steps/min) 78.5 ± 7.2 112.4 ± 3.2 p=.009 
Step Length (cm) 50.1 ± 4.6 73.9 ± 2.7 p<.001 
Stride Length (cm) 100.6 ± 9.3 148.0 ± 5.4 p<.001 
Step Length Variability (cm) 6.7 ± 3.2 1.9 ± 0.3 p=.003 
Stride Length Variability (cm) 10.6 ± 1.9 3.1 ± 0.5 p=.003 
Swing (% of gait cycle) 34.0 ± 1.2 39.2 ± 0.3 p=.004 
Stance (% of gait cycle) 66.0 ± 1.2 60.9 ± 0.3 p=.004 
Double Support (% of gait cycle) 31.3 ± 2.4 21.7 ± 0.7 p=.006 
    
Fast Walking    
Velocity (m/s) 1.0 ± 0.1 2.1 ± 0.1 p<.001 
Cadence (steps/min) 89.9 ± 7.2 138.3 ± 3.8 p=.001 
Step Length (cm) 64.0 ± 4.6 93.7 ± 3.1 p<.001 
Stride Length (cm) 128.5 ± 9.4 187.5 ± 6.2 p<.001 
Step Length Variability (cm) 6.7 ± 1.0 2.5 ± 0.2 p=.003 
Stride Length Variability (cm) 10.4 ± 1.6 3.9 ± 0.4 p=.004 
Swing (% of gait cycle) 38.1 ± 0.7 42.2 ± 0.4 p<.001 
Stance (% of gait cycle) 61.9 ± 0.7 57.8 ± 0.4 p<.001 
Double Support (% of gait cycle) 22.9 ± 1.3 15.6 ± 0.9 P<.001 
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Balance 
Table 3 summarizes postural stability indices for the FA and control groups.  
Subjects with FA exhibited significantly higher postural stability indices (OSI, API and 
MLI) than controls during quiet standing with eyes open (EO) (p<0.05) and with eyes 
closed (EC) (p<0.01). Higher indices denote worse postural stability. The OSI with EO 
and EC was 2.9- and 4.8-fold greater than control subjects at baseline, respectively. 
The API with EO and EC was 2.6- and 4.5- fold greater, while MLI with EO and EC was 
3.2- and 6.0-fold greater than controls, respectively. Additionally, postural stability 
parameters in controls did not differ with EO or EC, whereas, in FA subjects these 
parameters doubled with EC compared to EO.   
Table 4 summarizes limits of stability parameters for the FA and control groups.  
Of the 8 FA subjects tested, 1 was unable to perform the LOS test, and thus, this 
individual and the corresponding control were removed from the LOS analysis.  The 
remaining individuals with FA required 72% more time to complete the LOS test than 
controls (p<0.05).  Further, these individuals had an overall directional control score of 
35%, which was 50% less than controls (p<0.05). All LOS directional control scores 
were significantly different between the two groups, with the exception of the left 
directional control score (p=0.057). During performance of the LOS test, subjects with 
FA exhibited undershooting and overshooting of the targets, as well as extraneous 
movements.  
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Table 3. Baseline Postural Stability  
 
All values expressed as means ± SEM. Paired t-tests were used to compare FA to 
control subjects at baseline.  
 
Table 4. Baseline Limits of Stability  
 
All values expressed as means ± SEM. Paired t-tests were used to compare FA to 
control subjects at baseline.  
  
FA (n=8) 
 
Controls (n=8) 
 
p value 
 
Overall Stability Index (OSI) 
 
   
          Eyes Open 2.9 ± 0.6 1.0 ± 0.2 p=.018 
          Eyes Closed 5.7 ± 0.9 1.2 ± 0.2 p=.003 
 
Anterior Posterior Index (API)    
          Eyes Open 1.8 ± 0.4 0.7 ± 0.1 p=.039 
          Eyes Closed 3.6 ± 0.7 0.8 ± 0.3 p=.009 
 
Medial Lateral Index (MLI)    
          Eyes Open 1.9 ± 0.5 0.6 ± 0.1 p=.033 
          Eyes Closed 3.6 ± 0.6 0.6 ± 0.2 p=.005 
 
 
                          
                FA (n=7) 
 
Controls (n=7) 
 
p value 
    
Time (sec) 49.2 ± 3.4 28.6 ± 0.9 p=.001 
 
Directional Control Score (%) 
          Overall  
 
 
34.5 ± 6.0 
 
 
67.8 ± 4.8 
 
 
p=.012 
          Forward  44.9 ± 6.6 70.2 ± 3.3 p=.010 
          Backward  47.6 ± 5.7 68.0 ± 5.8 p=.032 
          Right  49.7 ± 6.0 75.7 ± 5.9 p=.037 
          Left  45.0 ± 9.8 78.1 ± 6.1 p=.057 
          Forward Right 41.9 ± 4.5 65.0 ± 5.8 p=.041 
          Forward Left  38.6 ± 7.3 68.5 ± 5.5 p=.042 
          Backward Right  37.8 ± 7.5 73.6 ± 3.5 p=.011 
          Backward Left  35.6 ± 7.5 69.0 ± 5.4 p=.023 
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Correlations 
To ascertain whether temporal demographic data, clinical rating scale scores and 
gait and balance parameters were related at baseline, data from FA patients were 
subjected to correlational analyses [Spearman’s (ρ) for BBS and FARS; Pearson’s (r) 
for all other variables]. Results indicated no significant correlations between subjects’ 
age and gait or balance measures. Disease duration correlated with: FARS total scores 
(r=.855, p=0.007); OSI with eyes open (r=.787, p=0.020); and MLI with eyes open 
(r=.934, p=0.001. FARS total scores correlated with MLI with eyes open (ρ=.711, 
p=0.048); but did not correlate with any other variables (p>0.05). Further, FARS upright 
stability scores did not correlate with any variables (p>0.05).  
Relationships between balance measures and gait parameters are shown in 
Table 5. Berg Balance Scale scores correlated negatively with step length variability for 
comfortable and fast walking (p<0.001) and with stride length variability for comfortable 
and fast walking (p=0.007 and p=0.011, respectively), but did not correlate with any 
other gait parameters (p>0.05). Although not shown in the table, the BBS also 
correlated positively with the LOS right directional control scores (ρ=.883, p=0.008), 
forward left directional control scores (ρ=.847, p=0.016) and the backward left 
directional control scores (ρ=.883, p=0.008).  
Quantitative balance parameters also correlated with gait parameters at baseline. 
Although OSI with eyes open did not correlate with gait parameters, OSI with eyes 
closed was positively correlated with stride length variability during fast walking 
(p=0.47). The API with eyes open correlated only with step length variability during 
comfortable walking (p=0.037). In contrast, API with eyes closed correlated only with 
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stride length variability during fast walking (p=0.044). The MLI with eyes open was not 
associated with any gait parameters. The MLI with eyes closed did not correlate with 
gait variability, but did correlate with percent of the gait cycle in swing, stance and 
double limb support for comfortable walking (p=0.022, p=0.023 and p=0.018, 
respectively).  
Time to complete the LOS test correlated with step length variability for 
comfortable and fast walking (p=0.004 and p=0.020, respectively) and with stride length 
variability for comfortable and fast walking (p=0.002 and p=0.017, respectively). Finally, 
the LOS overall directional control scores correlated negatively with step length 
variability for comfortable and fast walking (p=0.035 and p=0.017, respectively) and with 
stride length variability during comfortable and fast walking (p=0.036 and p=0.014, 
respectively). No other objective balance parameters were associated with gait 
parameters at baseline (p>0.05).   
 
Longitudinal Changes in Gait  
 
Gait Velocity and Cadence  
The mean gait velocity and cadence over 12 months for controls and over 24 
months for FA subjects are shown in Figure 4. There were no significant changes in 
these parameters from baseline to 12 months for controls as determined using paired t-
tests (p>0.05). In subjects with FA, gait velocity declined by 25% and 30%, while  
                    .
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Table 5. Relationship between Balance Measures and Gait Parameters  
 
Correlation coefficients (Spearman’s ρ for Berg Balance Scale scores and Pearson's r for postural stability and limits of 
stability measures) denote the relationships between gait parameters during comfortable and fast walking and balance 
measures. Significant (p<0.05) correlations are bolded.
    
 
Berg 
Balance 
Scale 
Scores 
 
Postural Stability 
 
Limits of Stability 
OSI  
Eyes  
Open 
OSI 
Eyes 
Closed 
API 
Eyes 
Open 
API  
Eyes 
Closed 
 
MLI 
Eyes 
Open 
MLI 
Eyes 
Closed 
Time 
(sec) 
Overall 
Directional 
Control 
Score (%) 
 
Step Length Variability 
         
      Comfortable Walking -0.946 0.576 0.494 0.738  0.429 .331 .417 0.914 -0.789 
      Fast Walking -0.946 0.511 0.516 0.703 0.459 .273 .426 0.833 -0.845 
Stride Length Variability          
      Comfortable Walking -0.850 0.373 0.619 0.584 0.616 .121 .461 0.942 -0.787 
      Fast Walking -0.826 0.246 0.712 0.503 0.719 .006 .524 0.844 -0.857 
% of Gait Cycle in:          
      Swing phase .371 -.071 -.672 .103 -.437 -.163 -.781 -.222 .120 
      Stance phase -.371 .071 .667 -.107 .432 .165 .778 .218 -.114 
      Double Limb Support -.371 .097 .679 -.082 .434 .188 .796 .217 -.123 
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cadence decreased by 17% and 21% during comfortable and fast walking, respectively, 
from baseline to 24 months. 
A linear mixed effect (LME) model was applied to determine whether gait 
parameters exhibited a significant linear change from baseline to 24 months in subjects 
with FA. Using this LME model, mean gait velocity during comfortable walking 
demonstrated a significant 0.008 m/s average unit decrease per month over 24 months 
(β=-0.008, SE=0.002, p=0.002). Mean gait velocity during fast walking demonstrated a 
significant 0.01 m/s average unit decrease per month (β=-0.013, SE=0.003, p=0.003). 
Similarly, mean cadence exhibited a significant average unit decrease per month during 
both comfortable and fast walking (0.61 steps/min, β=-0.610, SE=0.227, p=0.031 and 
0.77 steps/min β=0.766, SE=0.272, p=0.026, respectively) over 24 months. 
 
Step and Stride Length  
Mean step and stride lengths over 12 months for controls and over 24 months for 
FA subjects are shown in Figure 5. There were no significant changes in these 
parameters from baseline to 12 months for controls (p>0.05). Step and stride length 
decreased by 14% and 18% for comfortable and fast walking, respectively, in subjects 
with FA over 24 months.   
Using LME modeling, step and stride length exhibited significant linear changes 
over 24 months. Mean step length during comfortable walking exhibited a significant  
0.32 cm average unit decrease per month over 24 months (β=-0.315, SE=0.091, 
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B        
      
Figure 4. Gait Velocity and Cadence 
*Asterisks indicate significant linear change (p<0.05) over 24 months as determined 
using LME model.  
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p=0.010), while mean step length during fast walking showed a significant 0.48 cm  
average unit decrease per month (β=-0.4761, SE=0.140, p=0.012). Mean stride length 
for comfortable walking demonstrated a significant 0.64 cm average unit decrease per 
month (β=-0.636, SE=0.184, p=0.011), while mean stride length during fast walking 
revealed a significant 0.96 cm average unit decrease per month (β=-0.955, SE=0.288, 
p=0.013).  
 
Step and Stride Length Variability 
The mean step and stride length variability over 12 months for controls and over 
24 months for FA subjects are shown in Figure 6. There were no significant changes in 
these parameters from baseline to 12 months in controls (p>0.05). Step length 
variability increased by 20% and 29%, and stride length variability increased by 16% 
and 24% for comfortable and fast walking, respectively, in subjects with FA from 
baseline to 24 months.  
Using LME modeling, step length variability demonstrated a significant linear 
change over time. Step length variability during fast walking demonstrated a 0.10 (cm) 
average unit increase per month from baseline to 24 months (β=0.098, SE=0.029, 
p=0.012). However, no significant linear change was found for step length variability 
during comfortable walking or for stride length variability during either comfortable or 
fast walking (p>0.05).  
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Figure 5. Step and Stride Length 
*Asterisks indicate significant linear change (p<0.05) over 24 months as determined 
using LME model.  
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Figure 6. Step and Stride Length Variability 
*Asterisks indicate a significant linear change (p<0.05) over 24 months as determined 
using LME model 
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           Percent of Gait Cycle in Swing, Stance and Double Limb Support 
Mean percent of the gait cycle spent in swing, stance and double limb support 
from baseline to 12 months for controls and from baseline to 24 months for FA subjects 
are shown in Figure 7. There were no significant changes in these parameters from 
baseline to 12 months in controls (p>0.05). For subjects with FA, percent of the gait 
cycle spent in swing phase decreased 10% and 14% for comfortable and fast walking, 
respectively, while percent of the gait cycle spent in stance phase increased 5% and 8% 
for comfortable and fast walking, respectively. Percent of the gait cycle spent in double 
limb support increased by 19% and 32% for comfortable and fast walking, respectively.  
Using LME modeling, certain gait variables exhibited a significant, non-linear 
quadratic relationship indicating that the rate of change (slope of the line) was 
dependent on the time elapsed. All variables as a percentage of the gait cycle during 
comfortable walking exhibited a significant non-linear quadratic relationship. There was 
a significant non-linear, quadratic relationship for swing percent of the gait cycle during 
comfortable walking (β=-0.012, SE=0.005, p=0.037). Similarly, there was a significant 
non-linear, quadratic relationship for stance (β=0.012, SE=0.005, p=0.036) and double 
limb support (β=0.026, SE=0.011, p=0.038) percent of the gait cycle during comfortable 
walking, indicating that the rate of change increased with time from baseline to 24 
months. There were no significant changes in percent of the GC spent in swing, stance 
or double limb support during fast walking from baseline to 24 months (p>0.05).  
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Figure 7. Percent of Gait Cycle in Swing, Stance and Double Limb Support 
*Asterisks indicate significant non-linear quadratic change (p<0.05) over 24 months 
using LME model. 
A 
B 
C 
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Longitudinal Changes in Balance  
 
  Berg Balance Scale  
Berg Balance Scale scores for individual FA subjects are shown in Figure 8a, 
while mean scores for FA and control groups are shown in Figure 8b.  One subject with 
FA had lower BBS scores than the other FA subjects at all testing sessions. She also 
had the longest disease duration (16 years) compared to the other subjects. 
Additionally, the two subjects with LOFA (F6 and F7) and the subjects with incomplete 
genetic information (F8) displayed higher BBS scores than the other FA subjects at all 
testing sessions. Subjects with FA exhibited a decline in mean BBS scores of 7% at 12 
months, and 18% by 24 months at which time the mean BBS score was 36 with a range 
from 11 to 49. By 24 months, 5 of 7 subjects with FA fell below the BBS cut-off score of 
40, which is indicative of very high fall risk. Berg Balance Scale scores for the control 
group did not change from baseline to 12 months (p>0.05).  
The LME model was applied to determine whether BBS scores demonstrated a 
significant linear change from baseline to 24 months in subjects with FA. BBS scores 
demonstrated a significant linear change over time. The mean BBS scores exhibited a 
significant 0.27 average unit decrease per month over 24 months (β=-0.266, SE=0.053, 
p=0.001) as displayed in Figure 8b.  
 
Postural Stability  
  Mean postural stability parameters (OSI, API and MLI) over 12 months for 
controls and over 24 months for FA subjects are shown in Figure 9. In the control group, 
there were no significant changes in postural stability parameters from baseline to  
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Figure 8. Berg Balance Scale  
* Asterisks indicate a significant linear change (p<0.05) over 24 months as determined 
using LME model.  
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12 months as determined using paired t-tests (p>0.05). Postural stability parameters 
increased from baseline to 24 months during testing with both eyes open (EO) and eyes 
closed (EC) in FA subjects, denoting worsening postural control. OSI increased 24% 
and 33% with EO and EC, while API increased 25% and 40% and MLI increased 22% 
and 24% with EO and EC, respectively.  
The LME model was applied to determine whether postural stability parameters 
(OSI, API, and MLI) demonstrated a significant linear change from baseline to 24 
months. The OSI and API with EO and EC demonstrated a significant linear change 
from baseline to 24 months. Mean OSI with EO demonstrated a significant 0.028 
average unit increase per month from baseline to 24 months (β=0.028, SE=0.009, 
p=0.013).  Additionally, there was a significant effect of time for OSI with EO (β=0.002, 
SE=0.001, p=0.037) indicating that the rate of change increased as months elapsed 
from baseline to 24 months. Mean OSI with EC revealed a significant 0.089 average 
unit increase per month over 24 months (β=0.089, SE=0.028, p=0.016).  Mean API with 
EO demonstrated a significant 0.022 average unit increase per month over time 
(β=0.022, SE=0.008, p=0.025). Mean API with EC revealed a significant 0.023 average 
unit increase per month over 24 months (β=0.023, SE=0.647, p=0.011).  Similar to OSI 
with EO, there was a significant effect of time for API with EC (β=-0.006, SE=0.002, 
p=0.018). The MLI with EO demonstrated a significant non-linear, quadratic relationship 
using the LME model (Figure 9c). The average unit increase per month for MLI with EO 
was not significant (β=0.015, SE=0.008, p=0.112). However, a significant non-linear, 
quadratic relationship was found for MLI with EO (β=0.002, SE=0.000, p=0.042) 
indicating that the rate of change increased over time.   
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Figure 9. Postural Stability  
* Asterisks indicate a significant linear (or non-linear) change (p<0.05) in FA group over 
24 months as determined using LME model   
A 
B 
C 
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Limits of Stability   
Limits of stability parameters reflect dynamic standing balance. Mean LOS 
parameters over 12 months for controls and over 24 months for FA subjects are shown 
in Figure 10. In the control group, with the exception of the forward directional control 
score (p<0.05), no other significant changes in LOS scores were apparent. The forward 
directional control score (depicted in Figure 10c) increased from baseline to 12 months 
in controls as determined using paired t-tests (t=-3.706, p=0.008), indicating an 
improvement in dynamic balance. One FA subject was unable to complete the LOS test, 
therefore, results are based on 7 subjects with FA and their 7 matched controls. 
Individuals with FA took longer to complete the LOS task and had an overall directional 
control score nearly half that of controls.  In subjects with FA, time to complete the LOS 
test increased by 2%, while the overall directional control score decreased by 9% from 
baseline to 24 months. 
Linear mixed effect modeling was applied to determine whether limits of stability 
(LOS) parameters exhibited a significant linear change from baseline to 24 months in 
subjects with FA. The model revealed no significant changes in either time to complete 
the LOS test (Figure 10a) or in the overall directional control scores (Figure 10b) from 
baseline to 24 months. LME modeling did reveal a significant linear change in the 
backward directional control scores over 24 months as depicted in Figure 10d. The 
mean backward directional control score exhibited a significant 0.71 average unit 
decrease per month from baseline to 24 months in subjects with FA (β=-0.713, SE= 
0.238, p=0.024).  
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Figure 10. continued on next page  
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C     
             
 D  
              
Figure 10. Limits of Stability  
*Asterisk indicates significant change in control group over 12 months using paired t-
test. **Asterisk indicates significant linear change in FA group over 24 months as 
determined using LME model (p<0.05). 
* 
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Correlations  
 
 
Temporal Demographic Variable and Gait and Balance Correlations 
Pearson’s product correlation coefficient (r) was employed to assess the 
relationship between temporal demographic and gait and balance variables at 24 
months in subjects with FA. Subject age was not correlated with any variable at 24 
months (p>0.05). Disease duration was positively correlated with step length variability 
during fast walking (r=.761, p=0.047), MLI with EO (r=.797, p=0.032) and with the 
backward/right directional control scores (r=.891, p=0.017). A relationship was identified 
between years since FA diagnosis and OSI with EO (r=0.796, p=0.032). Temporal 
demographic variables were not correlated with any other balance or gait variables 
(p>0.05). 
 
Clinical Rating Scale Scores and Gait and Balance Correlations   
Correlations among clinical rating scale scores and gait and balance parameters 
are summarized in Table 6.  Spearman’s rank correlation coefficient (ρ) was used to 
investigate the relationship between BBS and FARS scores and balance and gait 
parameters for subjects with FA at 24 months. There was a significant negative 
correlation between BBS scores and MLI with EC (p=0.014). A significant positive 
correlation was revealed between BBS scores and the LOS forward directional control 
score (p=0.042). The BBS scores were positively associated with gait velocity during 
both comfortable and fast walking (p=0.036) and with cadence during fast walking 
(p=0.023). Berg Balance Scale scores were not related to any other balance or gait 
parameters (p>0.05). FARS total scores showed a positive correlation to API with EO 
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(p=0.003) and a negative correlation to the right, left and forward left directional control 
scores (p<0.01, p=0.005 and p=0.042, respectively). There was a significant, positive 
correlation between FARS total scores and step and stride length variability during fast 
walking (p=.007 and p=.014, respectively). FARS total scores were not related to any 
other balance or gait parameters (p>0.05). FARS Upright Stability scores were not 
related to any balance or gait variables (p>0.05).  
 
Quantitative Gait and Balance Correlations 
Correlations among balance and gait parameters are summarized in Table 6.  
Pearson’s product correlation coefficient (r) was employed to assess the relationship 
between quantitative balance and gait parameters at 24 months in subjects with FA. 
There were several significant correlations identified between these parameters, 
particularly, between postural stability parameters and step and stride length variability. 
The OSI with EC was positively correlated with stride length variability during 
comfortable walking (p=0.006) and with step and stride length variability during fast 
walking (p=0.014 and p=0.004, respectively).  A relationship was revealed between API 
with EO and step length variability during comfortable walking (p=0.025). In addition, 
there was a positive correlation between API with EC and stride length variability during 
comfortable walking (p=0.008) and step and stride length variability during fast walking 
(p=0.047 and p=0.024, respectively). MLI with EC was negatively correlated with gait 
velocity during comfortable walking (p=0.018).  
The LOS overall directional control scores were negatively associated with step 
length variability during fast walking (p=0.038) only. The right directional control scores 
73 
 
were negatively correlated with step and stride length variability during fast walking 
(p=0.006 and p=0.018, respectively); as were the left directional control scores (p=0.008 
and p=0.039, respectively). The forward/right directional control scores were negatively 
correlated with step and stride length variability during comfortable walking (p=0.008 
and p=0.007, respectively); as were the forward/left directional control scores (p=0.008 
and p=0.006, respectively) and the backward/left directional control scores (p=0.023). 
No other balance parameters were significantly correlated with gait parameters at 24 
months (p>0.05). 
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Table 6. Correlations among Clinical Rating Scale Scores and Gait and Balance Parameters at 24 Months  
 
 
Correlation coefficients (Pearson’s (r); Spearman’s (ρ) for BBS and FARS) denoting relationships among clinical rating scale 
scores and gait and balance parameters. * signifies p<0.05 and significant correlations are bolded. LOS Directional control 
score (DCS), Forward (Fwd), Backward (Bwd), Step length variability (Step SD), Stride length variability (Stride SD), Swing 
percent of gait cycle (Swing %), Stance percent of gait cycle (Stance %), Double limb support percent of gait cycle (Double %)
                                                  Postural Stability                   Limits of Stability 
 
 BBS 
(ρ) 
FARS 
(ρ) 
OSI 
EC 
API 
EO 
API     
EC 
 MLI 
 EC 
Overall 
DCS 
Fwd 
DCS 
Bwd 
DCS 
Right 
DCS 
Left 
DCS 
Fwd 
Right 
DCS 
Fwd 
Left 
DCS 
Bwd 
Left 
DCS 
BBS(ρ) 
 
1.000 -.679 -.321 -.714 -.214  -.857* .429 .829* .771 .486 .257 .600 .657 .600 
FARS(ρ) 
 
-.679 1.000 .643 .929* .429  .750 -.771 -.714 -.200 -1.0* -.943* -.771 -.829* -.771 
Comfortable Gait (r) 
 
Velocity 
 
.786* -.286 -.264 -.403 .123  -.840* .043 .205 .231 .163 -.201 .375 .156 .491 
Step SD 
 
-.464 .714 .792 .815* .645  .601 -.682 -.649 -.083 -.741 -.678 -.925* -.924* -.874* 
Stride SD -.357 .679 .896* .565 .886*  .399 -.700 -.658 -.120 -.761 -.703 -.932* -.935* -.873* 
Fast Gait (r) 
 
               
Velocity .786* -.286 -.245 -.355 .118  -.773 .240 .413 .301 .303 -.034 .376 .161 .583 
Cadence .821* -.429 -.146 -.387 .262  -.800 .209 .363 .539 .307 -.061 .166 -.070 .420 
Step SD .429 .893* .855* .686 .761*  .504 -.836* -.712 -.315 -.938* -.928* -.701 -.737 -.719 
Stride SD -.464 .857* .912* .611 .821*  .531 -.727 -.599 -.295 -.889* -.833* -.674 -.690 -.671 
Swing% 
 
.821 -.357 -.225 .038 .076  -.643 .181 .330 .582 .279 -.084 .089 -.146 .350 
Stance% 
 
-.821 .357 .225 -.038 -.076  .643 -.183 -.331 -.580 -.280 .082 -.089 .146 -.352 
Double% -.821 .357 .224 -.026 -.081  .651 -.186 -.335 -.574 -.282 .080 -.094 .141 -.358 
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CHAPTER FOUR 
DISCUSSION AND CONCLUSIONS 
 
The purpose of this study was to characterize the gait and balance disorder in 
adults with FA and to investigate changes over time in quantitative gait and balance 
parameters and the Berg Balance Scale. Additionally, this study investigated the 
relationship among temporal demographic variables, clinical rating scale scores and gait 
and balance parameters. This is the first longitudinal study to investigate changes in 
both gait and balance parameters and clinical rating scales in adults with FA.  
 
Gait  
At baseline, adults with FA exhibited all of the classic signs of gait ataxia (Ilg et 
al., 2007; Morton et al., 2003; Morton et al., 2004, 2007; Palliyath et al., 1998; Stolze et 
al., 2002). Although researchers have studied the gait disorder of individuals with FA 
(Croarkin et al., 2009; Milne et al., 2014; Serrao et al., 2012), there is very limited 
information on balance deficits in FA (Diener et al., 1984; H. Diener et al., 1984; Ilg et 
al., 2009) and no studies have investigated the relationship between balance deficits 
and the gait disorder in this patient population. 
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Gait Speed 
 The control subjects in this study had an average gait velocity of 1.4 m/s during 
comfortable walking, representative of norms for adults in their age group (i.e. 1.3-1.5 
m/s) (Bohannon, 1997; Bohannon et al., 2011). Mean gait velocity in adults with FA (0.7 
m/s) was not only significantly slower than controls, but 6 of 8 subjects with FA walked 
below speeds required for community ambulation, considered faster than 0.8 m/s (Fritz 
et al., 2009). These results are consistent with studies reported for individuals with a 
variety of cerebellar ataxias (Morton et al., 2003; Morton et al., 2010; Palliyath et al., 
1998) and with reports of reduced gait velocity in people with FA across age ranges 
(Croarkin et al., 2009; Gouelle et al., 2013; Milne et al., 2014) The present longitudinal 
study extends the results of previous cross-sectional studies and demonstrated a 
significant decline in gait velocity and cadence during both comfortable and fast walking 
over 24 months in adults with FA. By 24 months, FA subjects had an average gait 
velocity of 0.51 m/s for comfortable walking and 0.69 m/s for fast walking; both falling 
below the speed considered necessary for community ambulation. Self-selected walking 
speed is considered a valid, reliable, sensitive and specific measure, which correlates 
with functional abilities, balance confidence, and falls risk (Fritz et al., 2009; Studenski 
et al., 2011). In addition, gait velocity is considered a global indicator of walking 
impairment with potential to predict future health status and functional decline, the need 
for adaptive or assistive devices, and whether the individual is capable of household or 
community ambulation (Fritz et al., 2009).  Significantly decreased gait velocity in adults 
with FA may be predictive of future functional decline in walking and the need for gait 
assistive devices or a wheelchair for community mobility.   
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Step and Stride Length 
In the present study, adults with FA had significantly shorter step and stride 
lengths than their healthy peers and exhibited a significant decline in these parameters 
over 24 months. Decreased step and stride length have been observed in people with 
ataxic gait and these impairments are thought to contribute to decreased gait velocity 
(Ilg et al., 2007; Morton et al., 2003; 2010; Palliyath et al., 1998).  Palliyath et al. (1998) 
and Ilg et al. (2007) reported that people with cerebellar degeneration showed 
significantly reduced step and stride lengths compared to healthy individuals, which the 
authors proposed contributed to slower gait velocities. Other researchers reported that 
subjects with FA exhibited shorter step lengths than subjects with SCA and both groups 
walked slower than healthy controls (Serrao et al., 2012); these authors also found a 
strong correlation between step length and gait velocity. Croarkin and colleagues (2009) 
reported that adolescents with FA demonstrated a slower gait velocity, shorter stride 
lengths and took fewer steps per minute compared to healthy adolescents and children 
with less advanced disease. Reduced gait velocity was reported in a study of subjects 
with FA, whose ages ranged from 12 to 25 years  (Gouelle et al., 2013). These authors 
proposed that the subjects with FA reduced their gait velocity as a compensatory 
mechanism to increase stability while walking. However, they did not specifically test 
balance. Adults with FA have balance and gait impairments that may predispose them 
to falls. They may utilize compensatory strategies to limit their step lengths and reduce 
the speed of their walking to avoid loss of balance, falls and subsequent injury.  
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Gait Variability 
Gait variability is well documented in people with cerebellar ataxia and is related 
to functional walking impairment (Ilg et al., 2007; Morton et al., 2003; Palliyath et al., 
1998), gait speed (Schniepp et al., 2012; Wuehr et al., 2013) and falls (Schniepp et al., 
2014; Van de Warrenburg et al., 2005). Although increased gait variability is seen in 
many movement disorders, it is considered a characteristic feature of ataxic gait 
(Hausdorff, 2005; Ilg et al., 2013). Subjects with a variety of cerebellar ataxias exhibited 
significant variability in step and stride length, cadence, as well as step and stance time 
(Palliyath et al., 1998).  Serrao and colleagues (2012) emphasized the significant inter- 
and intra-subject variability of all spatiotemporal gait parameters in subjects with both 
FA and SCA, and proposed that it was difficult to describe a clear ataxic gait pattern due 
to the high level of variability. A recent study by Gouelle et al. (2013) evaluated gait 
variability in people with FA using a Gait Variability Index (GVI), which combines nine 
gait parameters to assess variability. The authors reported that gait variability was 
significantly higher in the FA group compared to healthy subjects and that the GVI was 
a useful method for studying variability in this population. The present study 
corroborates results of these studies by identifying significant step and stride length 
variability in adults with FA compared to healthy controls. Additionally, there was a 
significant increase in step length variability for fast walking from baseline to 24 months. 
Step and stride length variability were also greater during fast walking as compared to 
comfortable, self-selected walking. One study demonstrated that temporal gait variability 
was increased in patients with cerebellar and vestibular dysfunction and the amount of 
variability was related to the speed of walking (Schniepp et al., 2012). In the patients 
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with cerebellar dysfunction, variability increased during both slow and fast walking, but 
not during walking at comfortable, self-selected speeds. Another study demonstrated 
that both temporal and spatial variability were impaired in subjects with cerebellar ataxia 
and this depended on walking speed (Wuehr et al., 2013). These authors reported that 
increased stride time and stride length variability occurred at slow and maximal walking 
speeds. Additionally, they described reduced variability when healthy subjects walked at 
maximal walking speeds, in contrast to subjects with cerebellar ataxia. The authors 
proposed that the gait cycle may become more consistent with increasing walking 
speeds in healthy individuals, yet the increased variability at faster speeds in people 
with ataxia may reflect impaired cerebellar control of locomotor function (Wuehr et al., 
2013). Findings of increased gait variability during fast walking in adults with FA concur 
with these studies.  
Gait variability is considered a predictor of falls in the elderly and in people with 
neuromuscular disorders (Balasubramanian et al., 2009; Day et al., 2012; Grimbergen 
et al., 2008; Socie et al., 2013). Falls are also common in people with ataxia, including 
FA, and this is thought to relate to increased gait variability. Hausdorff (2005) stated that 
gait variability might be a stronger indicator of falls risk than average speed of walking, 
stride length or stride time in neurologic populations including ataxia. He proposed that 
gait variability may more strongly reflect the central nervous system’s ability to regulate 
gait and maintain a steady walking pattern. Schniepp et al (2014) reported a significant 
relationship between gait variability and falls risk, particularly during slow walking, in 
people with a variety of cerebellar ataxias. In addition, increased gait variability in an 
anterior-posterior direction (compared to a medial-lateral direction) was associated with 
80 
 
a higher risk of falls in the subjects. In the present study, step length variability 
increased significantly over 24 months for fast walking, but not for comfortable, self-
selected walking in adults with FA. These subjects may have slowed their gait speed to 
avoid the instability and increased variability which occurred during fast walking as a 
compensatory mechanism to avoid loss of balance. This is confirmed by findings of a 
significant correlation between step length variability during fast walking and balance as 
assessed by both objective balance measures and the Berg Balance Scale. Thus, 
increased gait variability could be considered indicative of balance impairment in adults 
with FA and worsening balance could lead to greater gait variability, particularly at 
increased speeds. 
 
Percent of Gait Cycle in Swing, Stance and Double Limb Support 
Over 24 months, adults with FA spent less percent of the gait cycle in swing 
phase and a greater percent of the gait cycle in stance phase and double limb support 
during comfortable walking. In a one year longitudinal study, Morton and colleagues 
(2010) reported that subjects with mixed cerebellar ataxias spent increased time in 
double limb support at 6 and 12 month follow-up compared with baseline, but these 
authors found no significant change in percent of time spent in stance phase.  Children 
without disability and normal adults tend to spend 40-44% of the gait cycle in swing 
phase and 56-60% of the gait cycle in stance phase. Within these age groups, the time 
spent in swing and stance phase typically does not change with age (Perry, 1992). A 
study of children and adolescents with FA demonstrated that percent of time spent in 
stance phase and double limb support was significantly longer than in normal 
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adolescents (Croarkin et al., 2009). Specifically, adolescents with FA, who were 
independent walkers, spent less time in swing phase (35%), and more time in stance 
phase (65%) and double limb support (30%) than healthy adolescents. These results 
correspond with findings in adults with FA, however, adults spent even less time in 
swing phase (31%) and more time in stance phase (69%) and double limb support 
(39%). The adults with FA in the present study may have more advanced disease and 
greater gait disability than adolescents with FA. This may also be a reflection of 
worsening dynamic balance in both populations (adults and adolescents). These 
individuals may spend more time with both feet in contact with the ground to avoid the 
inherent instability during swing phase, when they have to balance on one foot. Serrao 
and colleagues (2012), who described the ataxic gait pattern as wide based walking 
with increased double limb support duration, confirmed this gait dysfunction. The 
authors proposed this gait pattern was a strategy used to compensate for the wide 
oscillations of the center of mass and poor dynamic balance during walking in people 
with ataxia. Alternatively, they also indicated that increased stance duration and 
decreased swing duration and step length could be used to avoid loss of balance and 
falls because single limb support is the most unstable phase of gait (Serrao et al., 
2012). 
 
Balance  
Balance is critical to performing daily functional activities in both sitting and 
standing positions. Dynamic standing balance is particularly important as a person 
walks. Adults with FA demonstrated significantly higher postural stability indices, 
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decreased limits of stability scores and lower BBS scores than their healthy, peers 
indicative of balance impairment. This is the first natural history study to examine 
changes over time in balance in adults with FA using both objective measures and a 
balance specific clinical rating scale, the BBS. Additionally, this study investigated the 
relationship between balance parameters, the BBS and gait parameters.  
 
Berg Balance Scale  
 The FA subjects in this study had lower mean BBS scores compared to their 
healthy peers. All controls subjects attained the maximum BBS score at baseline and 
this did not change at 12 months. Subjects with FA demonstrated a significant decline in 
BBS scores at 24 months. The BBS proved to be an appropriate balance specific 
clinical rating scale for use in FA, and all subjects were able to perform all test items 
within 15-20 minutes. The BBS has been shown to be a valid and reliable balance 
assessment for community dwelling elderly and people with other neurological disorders 
(Datta et al., 2012; Muir et al., 2008) Additionally, the BBS has been shown to be 
correlated with measures of postural sway using dynamic posturography (Berg et al., 
1992). Attainment of a BBS score less than 45 indicates increased falls risk (Berg et al., 
1992), while scores less than 40 are associated with a near 100% risk for falls 
(Shumway-Cook et al., 1997). Two of 8 FA subjects in the present study demonstrated 
BBS scores below the cut-off for falls risk at baseline, while 5 of 7 FA subjects fell below 
the lower cut-off score of 40 by 24 months. This indicates that the majority of FA 
subjects in this study were at high risk to fall by the end of the study. Four subjects with 
FA, who had been ambulatory at baseline, had begun using a wheelchair as their 
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primary means of community mobility by the end of the study. Although balance 
impairment is not a cause of all types of falls and is not present in all people who fall, it 
has been shown to increase a person’s risk for falling (Muir et al., 2008).  
 The BBS has been used in other longitudinal studies to investigate change in 
balance over time in the community dwelling elderly (Muir et al., 2008), in people with 
spinal cord injury (Datta et al., 2012), and in those with stroke (English et al., 2006; Mao 
et al., 2002). Muir and colleagues (2008) found the BBS had good discriminate ability to 
predict multiple falls in elderly individuals, who were tested monthly for one year. 
Another study reported the BBS captured a significant amount of variation in balance 
recovery in subjects with incomplete spinal cord injury and correlated well with the 10 
meter walk test, 6 minute walk test, and SCI Functional Ambulation Index (Datta et al., 
2012). The BBS was able to discriminate between those with SCI who were slower to 
recover balance over time from those with faster balance recovery. Recently, a Delphi 
survey was conducted on balance assessments used with individuals with a variety of 
cerebellar ataxias (Winser et al., 2014). These authors suggested that balance 
assessment in people with ataxia is challenging secondary to a lack of standardized 
assessments. The BBS, the Scale for the Assessment of Ataxia (SARA) and the Timed 
Up and Go were identified as the best outcome measures to use with the ataxia 
population; with 75% consensus among the experts surveyed (Winser et al., 2014). The 
BBS was determined to have excellent inter-rater reliability, low measurement error and 
was able to discriminate between ataxic fallers and non-fallers. Ilg and colleagues 
(2009) used the BBS, SARA, ICARS and motion analysis to assess balance, gait and 
disease severity in subjects with a variety of degenerative ataxias before and after a 4 
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week intensive coordination training program. They reported significant improvements in 
BBS, SARA and ICARS scores for all groups following intervention, but the cerebellar 
ataxia group showed retention of improvements 8 weeks after treatment, whereas those 
with sensory ataxias did not (Ilg et al., 2009). In the present study, the BBS was found 
to be useful and appropriate as a balance specific assessment for adults with FA. In 
addition, this test demonstrated sensitivity to change over time. The BBS would have to 
be tested in a much larger cohort of subjects with FA to assess its psychometric 
properties. 
 
 Postural Stability and Limits of Stability 
Postural stability and LOS were tested on the Biodex Balance System SD. 
During the postural stability test, the greater the movement of an individual’s center of 
pressure around a center point on the balance platform, the higher the postural stability 
index generated by the system (Arnold et al., 1998; Sherafat et al., 2013). Adults with 
FA demonstrated significantly higher postural stability indices during quiet standing on 
the balance platform with eyes open and eyes closed compared to healthy individuals.  
Of particular note was the significantly higher postural stability indices with eyes closed, 
compared to healthy individuals. The overall stability index and the anterior posterior 
index were nearly 50% greater with eyes closed compared with eyes open in subjects 
with FA. Whereas, there was little difference in postural stability indices in controls with 
eyes open or closed. These findings would suggest subjects with FA have developed an 
over-reliance on vision to maintain balance, possibly to compensate for diminished 
somatosensation and proprioception in the lower extremities. It is well documented that 
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people with FA have somatosensory loss in the lower extremities due to involvement of 
the peripheral nerves, dorsal root ganglia, and spinal cord dorsal columns (Della Nave 
et al., 2008; Marmolino, 2011). Other populations with lower extremity sensory and 
proprioceptive loss demonstrate increased postural sway in static standing and 
decreased dynamic balance, which worsens with eyes closed (Cameron et al., 2010; 
Emam et al., 2009; Mauritz et al., 1979; Nardone et al., 2006; Sullivan et al., 2010).  
Normally, individuals use a combination of three sensory systems to maintain balance: 
vision, somatosensory and vestibular. People with impairment in one of these systems 
may utilize the other two systems to compensate for this loss. This may explain why 
adults with FA in the present study had significantly higher postural stability indices 
during quiet standing with eyes closed. In this situation, two systems required to 
maintain static balance, sensory and visual, were compromised.  
Dynamic standing balance deficits were also exhibited by adults with FA when 
performing the LOS task on the balance platform.  This test required the subject to shift 
their weight in different directions to move a cursor from a center target to peripheral 
targets. Individuals with FA took longer to complete the LOS task and had an overall 
directional control score nearly half that of controls, indicative of impaired dynamic 
balance.  Also, control subjects exhibited a relatively direct path of movement when 
performing the LOS task, whereas, FA subjects displayed undershooting and 
overshooting of the targets. Difficulty controlling movement of the COM during a 
dynamic balance task, as was observed in FA subjects during the LOS task, may be 
indicative of problems controlling COM movements during walking. Walking requires 
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ongoing adjustments of the COM over the base of support as the person shifts weight 
from one leg to the other, transitioning from stance phase to swing phase on each leg.  
Only three studies of postural sway in subjects with ataxia have included 
individuals with FA (Diener et al., 1984; 1984; Ilg et al., 2009). In one study, 8 subjects 
with FA exhibited an omnidirectional, low frequency postural sway with a stronger 
medial-lateral sway component during quiet standing, which worsened significantly with 
eyes closed (Diener et al., 1984). The present findings do not fully agree with this study. 
Although adults with FA showed significantly greater postural stability indices in both 
anterior-posterior and medial-lateral directions compared to controls, the anterior-
posterior index was greater and increased over time in subjects with FA.  Another study 
by Diener and colleagues (1984) reported that subjects with FA had an increased 
latency in EMG response of the anterior tibialis muscle and a backward loss of balance  
during a postural perturbation on a moving platform. The anterior tibialis muscles should 
have responded quickly to prevent the loss of balance backwards as the platform 
moved forward. Subjects with FA in the present study showed worsening anterior-
posterior postural stability indices and backward directional control scores over 24 
months, indicating that they may tend to lose balance forwards or backwards. However, 
they were standing on a non-moving balance platform so did not have to react to a 
perturbation. A third study investigated body sway of individuals with a variety of ataxias 
before and after rehabilitation interventions (Ilg et al., 2009), and reported that subjects 
with pure cerebellar degeneration showed improved postural sway following training, 
while those with sensory ataxia did not. The study included three subjects with FA, 
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however, their data was not analyzed separately from that of subjects with other types 
of sensory ataxia.  
Most balance research in ataxia has focused on individuals with SCA, who 
exhibit increased standing postural sway during quiet standing (Bakker et al., 2006; 
Mohan et al., 2009; Van de Warrenburg et al., 2005). Mohan and colleagues (2009) 
used the Biodex Balance System and reported higher postural stability indices (OSI, 
API & MLI) in subjects with SCA compared with healthy controls. The mean value of 
API was also significantly higher than MLI in subjects with SCA. Fourteen of twenty 
SCA subjects could not complete the LOS task on the Biodex, but those who did took 
significantly longer and had significantly lower directional control scores than controls 
(Mohan et al., 2009).  The findings of the present study parallel those of Mohan et al. 
(2009); the mean value of the anterior-posterior index was greater than the mean 
medial-lateral index in subjects with FA. Additionally, a significant decline in the overall 
stability index, anterior-posterior index and backward directional control scores over 24 
months were noted in adults with FA. Van de Warrenburg and colleagues (2005) used 
angular velocity transducers mounted on the backs of 11 subjects with SCA and 11 
healthy controls to quantitatively measure trunk angle displacement and angular velocity 
in a pitch (AP) and roll (ML) plane as subjects performed a series of standing and gait 
tests. They determined that trunk angle displacement and angular velocity were 
significantly larger in SCA patients than in controls.  Additionally, they noted trunk sway 
abnormalities were greater in the pitch (anterior-posterior) direction than in the roll 
(medial-lateral) direction. Standing on foam, particularly with eyes closed, led to a 
further increase in anterior-posterior trunk sway in this patient cohort. The authors 
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proposed the increased sway during standing on foam, particularly with eyes closed, 
was due to an absence of visual feedback and a distortion of proprioceptive input from 
the lower extremities (Van de Warrenburg et al., 2005). The response of these subjects 
with SCA was similar to that seen in adults with FA who demonstrated increased 
postural stability indices with eyes closed compared to eyes open during quiet standing.  
People with FA have neurologic involvement beyond the cerebellum and its 
pathways so they present differently from individuals with strictly cerebellar 
degeneration. Additionally, in FA, there is involvement of the peripheral nerves, cell loss 
in the dorsal root ganglia, and degeneration of the dorsal columns of the spinal cord. 
MRI studies have shown significant shrinkage in the cervical spinal cord in people with 
FA (Chevis et al., 2013). Only later in the disease process do brainstem nuclei and the 
cerebellum become involved. There are certain limitations when comparing FA balance 
and gait deficits to individuals with strictly cerebellar degeneration. FA does show some 
similarities to the neurologic sequelae of chronic alcoholism, where a combination of 
peripheral neuropathy and cerebellar involvement is seen. Using posturography, 
anterior-posterior postural sway was shown to be more pronounced than medial-lateral 
sway in subjects with chronic alcoholism and cerebellar anterior lobe atrophy (Mauritz et 
al., 1979). These subjects exhibited increased anterior-posterior postural sway with 
eyes closed, but were able to stabilize their body with eyes open. The authors 
conducted follow-up testing with the same subjects over five years and noted further 
increases in anterior-posterior postural sway as the subject’s disease progressed 
(Dichgans et al., 1983). The present study demonstrated similar findings over two years, 
i.e., significant increases in anterior-posterior postural stability indices, which was worse 
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with eyes closed. People with chronic alcoholism experience peripheral neuropathy and 
cerebellar vermian loss, which is thought to contribute to balance loss and gait ataxia 
even after months of sobriety (Fein et al., 2012; Smith et al., 2011; Sullivan et al., 2006, 
2010). These individuals exhibit abnormally long sway paths, preferential sway direction 
in an anterior-posterior plane and less postural sway with the use of stabilizing factors. 
Despite significant increased postural sway in alcoholics, these individuals were able to 
use visual and tactile cues to significantly reduce their postural sway (Sullivan et al., 
2010). In another study, Smith and Fein (2011) reported that gait and balance of male 
and female alcoholics can continue to recover following long term abstinence from 
alcohol. However, balance deficits persist especially during standing balance activities 
with eyes closed. People with FA showed lower postural stability indices with eyes open 
compared to eyes closed, yet were not able to use sensory cues to attain indices that 
approached their matched, healthy peers even with eyes open. In summary, the 
direction of impaired postural sway (AP) observed in people with SCA and chronic 
alcoholism was consistent with the greater anterior-posterior postural stability indices 
attained by adults with FA.  
The present study is the first to investigate both static and dynamic balance in 
adults with FA and identify correlations between balance and gait parameters. Morton 
and Bastian (2003) reported subjects with cerebellar damage and balance deficits 
demonstrate most of the classic features of gait ataxia, whereas subjects with primarily 
leg placement deficits did not. Leg placement deficits are indicative of lower extremity 
incoordination. The subjects with balance deficits were significantly impaired on 5 of 10 
measures of walking, whereas those with leg placement deficits were impaired on only 
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one measure of walking. Certain gait parameters, including stride length variability, were 
abnormal in the balance deficit subgroup, but not impaired in the leg placement deficit 
subgroup. These authors concluded that balance deficits are a stronger indicator of 
cerebellar ataxia during level ground walking than lower extremity coordination deficits 
(Morton et al., 2003). Other authors suggest the high level of gait variability seen in 
people with ataxia may represent a combination of balance impairment, lower extremity 
incoordination, and inaccurate strategies to prevent loss of balance while walking (Ilg et 
al., 2013). The present study demonstrated adults with FA have both static and dynamic 
balance deficits and there is a relationship between balance variables and gait 
parameters, which is consistent with findings of previous research.  
 
Longitudinal Research 
 The present study demonstrated statistically significant changes in both balance 
and gait parameters and the Berg Balance Scale in adults with FA over two years. 
There has only been one other longitudinal, natural history study of quantitative gait and 
balance parameters and clinical rating scales in individuals with cerebellar ataxia, but 
this study did not include subjects with FA (Morton et al., 2010). These investigators 
utilized instrumented gait and balance measures and the ICARS to study the natural 
history of change over one year in 16-69 years olds with a variety of cerebellar 
disorders. They divided subjects into three groups; those with degenerative cerebellar 
disease (degenerative group), subjects with “static” unchanging cerebellar lesions 
following stroke or tumor (static group), and healthy controls. Significant differences in 
gait and balance measures and ICARS scores were observed between cerebellar 
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subjects and healthy controls. There was significant worsening of ICARS total scores 
and ICARS posture and gait sub-scores over the three testing sessions (baseline, 6 
months and 12 months) in the degenerative group, but improvement in the static group. 
At baseline, the degenerative group demonstrated greater postural sway compared with 
static and control groups, but neither degenerative or static group exhibited significant 
change in postural sway or dynamic weight shifting over one year. The degenerative 
cerebellar group walked slower and took shorter strides, while the static group walked 
faster and took longer strides over one year.  However, changes in gait parameters 
were not statistically significant. These authors were unable to detect a statistically 
significant change in balance or gait parameters in subjects with a variety of cerebellar 
disorders over one year, but they did demonstrate significant change in ICARS scores 
(Morton et al., 2010). It is possible that one year may not have been long enough to 
detect a significant change in objective balance and gait measures. Another longitudinal 
study examined the rate of disease progression in people with FA over one and two 
years using the FARS and reported that the FARS could detect changes at two years 
but did not detect changes at one year (Friedman, 2010).  
The present longitudinal study demonstrated a gradual decline in both gait and 
balance in adults with FA over time, but these individuals were not involved in 
rehabilitation during the course of the study. Intervention studies have shown the benefit 
of physical therapy or adaptive equipment, but also emphasized these interventions 
only slow the decline inherent in degenerative diseases. Larger clinical trials with 
individuals with cerebellar or sensory ataxia have shown the benefit of physical therapy 
interventions and their effect on gait and balance over time (Ilg et al., 2010; 2009; Keller 
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et al., 2014; Missaoui et al., 2013; Miyai, 2012). Ilg and colleagues (2009) examined the 
effect of a 4 week intensive coordination training program for 16 patients with either 
cerebellar degeneration (n=10) or sensory ataxia (n=6). The sensory group included 3 
patients with FA, however, results for FA subjects were not analyzed separately. 
Primary outcome measures included the SARA, ICARS, BBS and balance and gait 
parameters attained using motion analysis. Assessments were conducted 8 weeks 
before, immediately before, immediately after, and 8 weeks after training. Results 
revealed a significant decrease in ataxia as measured by the SARA, as well as, 
improved static and dynamic balance in the cerebellar group immediately after training. 
Subjects with cerebellar ataxia exhibited a greater improvement in gait velocity, lateral 
body sway and limb coordination than the sensory group. Follow-up assessment 
revealed retention of improvements at 8 weeks for the cerebellar group, but not for the 
sensory ataxia group, The same authors conducted a follow-up study of the same 
subjects one year after the training program and reported that despite a gradual 
increase in ataxia due to disease progression in both groups, the cerebellar group 
retained improvements in ADLs and motor performance one year after training (Ilg et 
al., 2010). The sensory ataxia group exhibited less improvement after the 4 week 
training program with no retention at 8 weeks or one year follow-up. This longitudinal 
study was similar to the present study in that both used quantitative measures of gait 
and balance and clinical rating scales including the BBS to test changes in gait and 
balance over time. Ilg and colleagues (Ilg et al., 2010; 2009) were able to demonstrate a 
slowing of the decline in gait and balance in subjects with pure cerebellar ataxia using 
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intensive rehabilitation; whereas subjects with sensory ataxia including FA did not retain 
benefit from the program.  
 
Linear Mixed Effect Model 
This study incorporated a linear mixed effect (LME) model for statistical analysis. 
The LME model was determined to be a useful statistical method to investigate changes 
in gait and balance occurring over two years in adults with FA. This model was selected, 
in part, because one subject dropped out of the study after 12 months testing. The LME 
model allows more flexibility with fewer assumptions and more statistical power than 
alternative methods, such as repeated measures ANOVA (Tang et al., 2014). In 
addition, the model allows for the use of unbalanced data and does not exclude 
subjects with incomplete data while still describing how individuals and groups change 
over time (Finucane et al., 2007). Current findings are consistent with other studies, 
which have examined longitudinal changes in postural control and gait in other 
neurological populations (Lorenz et al., 2012; Mancini et al., 2012). Mancini and 
colleagues (2012) used 3D accelerometers mounted on the posterior trunk of 13 
subjects with Parkinson’s disease and 12 healthy control subjects to investigate 
changes in 4 measures of postural sway from baseline to 6 month and 12 month follow-
up. To assess longitudinal change in postural sway measures and differences between 
groups, these authors employed a LME model followed by a Bonferroni pairwise 
correction for multiple comparisons. Postural sway measures did not change in healthy 
controls over time and showed low variability between subjects. The patients with 
Parkinson’s disease were divided into 2 groups; those who began medications in the 
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first 3 months of the trial and those who did not. The untreated subjects showed an 
increase in all 4 measures of postural sway from baseline to 12 month follow-up 
suggesting a progressive worsening in balance over time, while those who took 
medication showed a slight decrease only in medial lateral sway measures. These 
authors concluded that the LME model was a robust statistical method for analyzing 
longitudinal change in quantitative balance measures in patients with Parkinson’s 
disease (Mancini et al., 2012). Lorenz and colleagues (2012) used the LME model to 
investigate progress over time in BBS scores, 6 minute walk test, and 10 meter walk 
test of 337 patients with incomplete spinal cord injury who were receiving locomotor 
training on a treadmill. They stated that the LME model was able to predict average 
performance on an outcome measure over time considering certain covariates while 
allowing for individual patient variation in recovery rates. Using the LME model, results 
showed a significant improvement on each outcome measure and significant 
attenuation of improvement over time. Subjects varied significantly across groups by 
ASIA impairment level and time since spinal cord injury and in their rates of change over 
time. These authors concluded that locomotor training on a treadmill resulted in 
significant improvement in functional outcome measures, including the BBS, and 
improvement increased as treatment sessions accumulated (Lorenz et al., 2012).  
 
Relationships among Variables 
Disease duration of subjects in the present study ranged from 6 to 16 years. The 
findings established a relationship between age of onset, disease duration and gait 
variability. Greater gait variability may be exhibited by adults with FA who have longer 
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disease duration. These findings concur with those determined in children and 
adolescents with FA and extend results to adults (Croarkin et al., 2009). Croarkin and 
colleagues (Croarkin et al., 2009) reported a negative correlation between age and gait 
velocity and between age and stride length in children and adolescents with FA. The 
authors suggested that disease progression in older adolescents with FA might lead 
them to walk more slowly and take shorter strides. This also suggests that disease 
onset at an earlier age in childhood may significantly affect walking ability by 
adolescence. Conversely, young adults, who have relatively later onset of disease in 
adolescence (as was the case in present study) may not experience a rapid decline in 
their walking until adulthood. Croarkin and colleagues (2009) emphasized the 
importance of quantifying gait parameters and investigating the association between 
age and age of FA symptom onset and gait parameters.  They suggest  this information 
could improve assessment of a child or adolescent’s disease status at different phases 
of maturation. We postulate that studies of FA gait and balance should focus on specific 
age groups or should cluster and analyze subject data by age rather than including 
subjects across multiple age groups to avoid the confounder of gait changes due to  
maturation in children and adolescents. Although the present study did not detect a 
significant correlation between subject’s age and gait or balance variables, disease 
duration did correlate with FARS total scores at baseline and with step length variability 
during fast walking at 24 months. Klockgether and colleagues (1998) studied disease 
progression in several different types of ataxia, including FA. They reported disease 
progression in FA and Multiple System Atrophy was faster than the other diseases 
studied.  In addition, they noted patients with early onset recessive ataxias, such as FA, 
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reached advanced disease stages at a younger age. Finally, they determined that time 
until confinement to a wheelchair was shorter for patients with FA who had earlier 
disease onset; specifically, the median time from disease onset to confinement to a 
wheelchair was 11 years (Klockgether et al., 1998). LaPean and colleagues (2008) 
examined disease progression, including loss of ambulation and ADLs, and the 
association of disease progression to GAA repeat length, age of onset, and age of 
diagnosis in a  study of 61 subjects with FA. They reported age at FA diagnosis was 
predictive of wheelchair use and was the most significant variable predicting loss of 
ambulation (La Pean et al., 2008). Thus, individuals with earlier disease onset appear to 
have a less favorable prognosis. Findings of the present study demonstrated a positive 
correlation between disease duration and gait variability in adults with FA. Increased 
gait variability in those with longer disease duration may increase the likelihood for loss 
of ambulation and dependence on a wheelchair for mobility.  
Our findings demonstrated a significant negative correlation between BBS scores 
and step and stride length variability at baseline. Lower BBS scores are indicative of 
worse static and dynamic balance and impaired dynamic balance has been shown to be 
related to greater gait variability (Schniepp et al., 2014). Our findings are in agreement 
with results of a study of people with incomplete SCI, who had reduced lower extremity 
somatosensation, proprioception, and muscle strength (Day et al., 2012). These authors 
reported an inverse relationship between BBS scores and gait variability in subjects with 
incomplete SCI. Specifically, they reported BBS scores were significantly inversely 
related to step length and anterior-posterior and mediolateral foot placement variability 
(Day et al., 2012). These authors proposed that intact dynamic balance for walking is 
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dependent on central nervous system integration of sensory information from the distal 
lower extremities and the subsequent motor output to execute the walking task (Day et 
al., 2012).  The BBS scores in adults with FA were related to both postural stability and 
limits of stability scores, as well as to gait velocity at 24 month follow-up. Specifically, 
lower BBS scores were related to lower limits of stability scores; the latter reflective of 
dimished dynamic standing balance. In addition, lower BBS scores were related to 
slower gait velocity and decreased cadence, which establishes evidence for the 
relationship between impaired balance and gait ataxia in adults with FA. FARS total 
scores were associated with the anterior-posterior postural stability index, limits of 
stability scores and with step and stride length variability during fast walking at 24 
months.  
 The present study demonstrated several significant relationships between 
objective balance and gait parameters. It is the first study to investigate the relationships 
between clinical rating scale scores and objective measures of both balance and gait 
and how these relationships change over time. The most striking finding was the strong 
and consistent relationship between postural stability indices, limits of stability scores, 
and step and stride length variability. The postural stability indices are an indicator of 
static standing balance, and do not relate as strongly to the balance required to perform 
a dynamic task like walking. The limits of stability scores, more indicative of dynamic 
balance, displayed a strong relationship to step and stride length variability at both 
baseline and 24 months. Others have illustrated a relationship between dynamic 
balance and gait variability in people with other neuromuscular disorders (Day et al., 
2012; Grimbergen et al., 2008; Socie et al., 2013). The present study is the first to 
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establish a significant relationship between dynamic balance impairment and gait 
variability in adults with FA. Milne and colleagues (2014) recently conducted a study of 
13 individuals with FA (ages 16-52 yrs.) investigating the relationship between 
spatiotemporal gait parameters at varying speeds, as measured by the GAITRite 
system, and clinical tests of disease severity (FARS, Timed 25 Foot Walk Test). They 
reported significant correlations between gait parameters (at self-selected, slow and fast 
walking speeds) and both FA disease duration and FARS total scores. During fast 
walking, gait speed and cadence declined with increased FARS scores and disease 
duration. There was also a correlation between the Timed 25 Foot Walk Test and mean 
gait velocity at all three speeds. The authors concluded spatiotemporal gait parameters, 
as measured by the GAITRite system, are a sensitive measure of the decline in gait 
observed in people with FA, however, this was not a longitudinal study. They suggested 
quantitative gait analysis may provide a more sensitive measure, which is able to detect 
more subtle changes in gait, than can be determined using performance measures such 
as the Timed 25 Foot Walk Test (Milne et al., 2014). Our longitudinal findings 
demonstrated that gait parameters, as measured by the GAITRite system, were 
sensitive to detect changes in gait over a two year period of time in adults with FA. The 
results differ from the previous study by establishing a significant relationship between 
FARS total scores and step and stride length variability during fast walking, but FARS 
total scores were not related to gait speed. FARS upright stability scores did not 
correlate with balance or gait parameters in the present study.  This is different from 
results presented by Milne (2014), who found an association between FARS upright 
stability scores and intra-individual gait variability. In summary, the present study 
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demonstrated significant relationships between clinical rating scale scores and objective 
gait and balance parameters in adults with FA; which corroborate findings of other 
studies of cerebellar ataxia and other neurological disorders.  
 
Limitations of the Study 
The main limitation of this study is the small sample size. It was difficult to recruit 
subjects because FA is a relatively rare disease.  Additionally, the inclusion criteria did 
not allow subjects to be involved in drug trials while participating in this study. Attrition 
resulted in loss of one subject after 12 month testing, therefore, data at 24 months are 
based on seven subjects with FA. Further investigation with a larger sample size will be 
needed to extend the results to a wider FA population.  
 
Implications of Findings 
Although this was a pilot study, it is the first longitudinal, natural history study of 
adults with FA to characterize gait and balance impairment and demonstrate changes in 
gait and balance over time using quantitative measures and clinical rating scales. This 
study examined the correlation between clinical rating scale scores, balance and gait 
parameters. Knowledge of balance and gait characteristics may assist physical 
therapists to predict future decline in functional ambulation in adults with FA. 
Significantly decreased gait velocity and increased gait variability, as observed in the 
present study, may be predictive of future functional decline in walking, as well as 
increased falls risk. For many individuals with FA, it is in young adulthood that balance 
and gait become progressively more involved. This leads to a loss of ambulation and 
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reliance on a wheelchair or other assistive devices for mobility. At the same time, this is 
a period in life when these individuals are pursuing an education, establishing careers, 
and supporting themselves or a family. Attainment of these important life goals are 
made more challenging by the worsening balance and gait disability. The results of this 
study may provide information to support the inclusion of physical therapy management 
enabling individuals with FA to ambulate independently for as long as possible.  
Physical therapists need to understand FA gait and balance deficits in order to provide 
evidence based interventions during optimal time periods. This knowledge would also 
allow patients, families, and health professionals to plan in terms of rehabilitation needs 
and the need for equipment or environmental modifications.  
 
Future Directions   
 A longer, longitudinal study (5-10 years) with a larger cohort of subjects with FA 
is needed to continue investigation of changes over time in gait and balance in this 
population. Future studies should include newer technology and software programs for 
quantitative gait and balance testing, but should retain the Berg Balance Scale and the 
FARS. Future longitudinal studies could include subjects across age groups, however, 
the cohort should be clustered by age allowing for separate analyses by age group. Use 
of instrumented measures could monitor possible improvement, or reveal a slowing of 
decline in gait and balance as an integral component of new drug trials. Finally, 
quantitative gait and balance measures and clinical rating scales could be utilized to 
investigate the evidence for neurorehabilitation interventions, which may also have a 
role in slowing the decline in balance and gait in people with FA. To date, most research 
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investigating rehabilitation interventions for FA have been single case studies or have 
not focused on the FA population exclusively (Goulipian et al., 2008; Harris-Love et al., 
2004; Ilg et al., 2010; 2009).   
 
Conclusions 
This is the first longitudinal study of adults with FA to show change over time in 
both gait and balance variables using both quantitative measures and clinical rating 
scales. This study provided a detailed characterization of the gait pattern of adults with 
FA and information regarding both static and dynamic balance. The Berg Balance Scale 
proved to be a sensitive assessment tool to detect change over time in balance in adults 
with FA.  
This study determined that the longer time since onset of FA symptoms, the 
more compromised the postural control and gait variability. We identified significant 
relationships between balance and gait parameters. A striking finding was the strong 
and consistent relationship between postural stability indices, limits of stability scores 
and step and stride length variability. A significant relationship between BBS and FARS 
total scores and gait variability was also shown. Quantitative measures of gait and 
balance, the GAITRite Mat and the Biodex Balance System, respectively, were sensitive 
measures able to detect change over time in gait and balance in this patient cohort.  
Future longitudinal studies of gait and balance in FA should include quantitative 
gait and balance measures in addition to clinical rating scales to investigate changes 
over time in a larger cohort of subjects. Knowledge of gait and balance impairment in 
this population is critical to physical therapists to provide appropriate adaptive and 
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assistive devices and to provide interventions during optimal time periods. Further, this 
information could assist all health professionals to predict future decline in functional 
mobility and assist in decision making as they provide care and treatment to individuals 
with FA.  
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